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ABSTRACT 
 
Directed Evolution of Phosphotriesterase for Stereoselective Detoxification of 
Organophosphate Nerve Agents. 
(December 2009) 
Ping-Chuan Tsai, B.S., National Tsing-Hua University 
Chair of Advisory Committee: Dr. Frank M. Raushel 
 
            The bacterial phosphotriesterase (PTE) from Pseudomonas diminuta possess 
very broad substrate specificity for organophosphorus compounds.  It is capable of 
hydrolyzing several insecticides including paraoxon and various chemical warfare agents 
such as sarin (GB), soman (GD), cyclosarin (GF) and VX.  The catalytic ability of PTE 
for the hydrolysis of paraoxon is close to the limit of diffusion of the reactant in solution.  
However, the catalytic activity of PTE for the organophosphate nerve agents is lower 
than that for paraoxon.  It was reported that the wild-type PTE preferentially catalyze the 
hydrolysis of the less toxic Rp- enantiomers of organophosphate nerve agents and their 
analogues than the more toxic Sp- enantiomers.  The first generation of PTE mutants that 
contains a modified substrate binding pocket was identified and it was observed that 
their catalytic activity towards the more toxic Sp- enantiomers organophosphate nerve 
agent analogues was enhanced.  The H254G/H257W/L303T mutant was shown to have 
a reversed stereoselectivity.  The kcat/Km values of this mutant towards the hydrolysis of 
the SpRc- and SpSc-enantiomers of the GD analogue and the Sp-enantiomer of the GF 
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analogue were enhanced by 73-, 543-, and 1340-fold relatively to the wile-type enzyme, 
respectively.   
            The second generation of PTE mutants were isolated and shown to have higher 
activity toward the Sp-enantiomers of the GD and GF analogues than the first generation 
mutants.  Saturation mutagenesis, in vitro screening and in vivo selection were 
conducted using the gene for the mutants from the first generation. The GWT-d3 mutant 
was identified as the most active PTE mutant towards the hydrolysis of the Sp-
enantiomers of the GD analogue, the kcat/Km values were 780- and 3530-fold higher than 
the wild-type enzyme toward the SpRc- and SpSc-enantiomers of the GD analogues.  The 
GWT-f5 mutant was the best PTE mutant towards the Sp-enantiomer of the GF 
analogue, the kcat/Km values were 15500-fold higher than the wild-type enzyme.  
             The X-ray crystal structures of the wild-type PTE and the G60A mutant were 
determined in the presence of the hydrolysis product diethyl phosphate and a product 
analogue cacodylate, respectively.  This result supports the reaction mechanism 
previously proposed by Dr. Sarah Aubert. 
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CHAPTER I 
INTRODUCTION 
 
            Bacterial phosphotriesterase (PTE) belongs to the amidohydrolase superfamily.  
The enzymes in this superfamily adopt a (β/α)8 barrel fold structure with conserved 
active site residues and one or two divalent cations (1).  PTE was found in two different 
soil bacteria, Pseudomonas diminuta MG and a strain of Flavobacterium sp. (2). This 
enzyme is of significant interest because of its ability to catalyze the detoxification of 
organophosphate insecticides and chemical warfare agents. PTE detoxifies paraoxon, a 
known pesticide, at rates close to the diffusion limit of enzymatic reactions. The kcat and 
kcat/Km values are ~104 s-1 and 108 M-1 s-1, respectively (3).  In addition, PTE is the only 
known enzyme to hydrolyze the most toxic nerve agent, VX (4).  
It has been shown that the organophosphate nerve agents, such as sarin, soman 
and VX, are more toxic as the Sp- stereoisomers than the Rp- stereoisomers (5).  
However, the catalytic activity of the wild-type PTE for the more toxic Sp- stereoisomers 
is not as efficient as the Rp- stereoisomers.  Rational design and directed enzyme 
evolution have been utilized to optimize the activity, stability, or substrate specificity of 
the enzyme by manipulating the protein structure of this enzyme (6).  Herein, PTE was 
subjected to rational design and directed evolution to optimize the active site structure 
for detoxification of organophosphate nerve agents.  
____________ 
This dissertation follows the style of Biochemistry. 
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Directed Enzyme Evolution 
            Directed evolution is a valuable tool used in protein engineering to control the 
power of natural selection in order to evolve proteins with desired properties not found 
in nature, such as enzymes with improved specificity, activity, stability, etc.  Rational 
design and directed evolution are two approaches currently being used. Rational design 
involves changing the amino acid sequence using site-directed mutagenesis. This 
technique requires a good understanding of protein structure, function and reaction 
mechanism.  Directed evolution does not require complete knowledge of the protein 
structure.  As shown in Figure 1.1, directed evolution starts from one or multiple genes, 
and creates a library of mutant genes by random mutagenesis or gene recombination.   
The resulting library is cloned into an expression vector and transformed into 
microorganisms for protein expression.   The functionally improved enzymes are then 
selected and identified through a carefully designed selection process or high-throughput 
screening methods.  
           There are several strategies that have been used to create randomized libraries of 
the targeted gene: saturation mutagenesis, error-prone PCR, DNA shuffling and E. coli 
mutator strains.  Saturation mutagenesis changes specific amino acids that are selected 
by mapping the structure of the enzyme active site.  This can be accomplished by several 
methods: cassette insertion (7), mutagenic oligonucleotide PCR amplification (8), or 
splicing overlap extension (SOE) of DNA fragments (9). 
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Figure 1.1  General scheme of directed evolution (6).  
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The cassette insertion method involves designing a pair of DNA oligonucleotide 
segments with degenerate codons at the target position. These DNA segments are then 
ligated into the targeted gene.  The mutagenic oligonucleotide PCR amplification utilizes 
primer pairs with degenerate codons at the target position.  QuickChange site-directed 
mutagenesis is performed using Pfu Turbo DNA polymerase.  The parental methylated 
DNA strands are then digested by DpnI. No ligation step is necessary, since the nicks in 
the replicated DNA are repaired after transformation into E. coli cells.  The method of 
splicing overlap extension (SOE) of DNA fragments requires execution of a separate 
PCR by amplifying multiple DNA fragments that overlap at the randomized codons in 
the target sequences.  Each primer pair is synthesized with a mismatched random 
nucleotide sequence in the middle, flanked on both sides by nucleotides that specifically 
anneal to the target regions.  These oligonucleotide fragments are then annealed by 
primerless PCR, the original full-length gene with randomized variants is formed.  The 
regular PCR using upstream and downstream primers is then done to amplify this 
randomized library.  The primers for mutagenic oligonucleotide PCR amplification,  
splicing overlap extension (SOE) of DNA fragments and the  DNA segments for cassette 
insertion contain the degenerate codon NNN or NNS (NNC and NNG) at designated 
positions.  The NNS codon is to eliminate two stop codons, TGA and TAA. 
Error-prone PCR utilizes error-prone DNA polymerase in the reaction; Taq 
polymerase is the commonly used enzyme due to its higher error rate.  The reaction 
conditions need to contain higher concentrations of MgCl2 than the normal PCR 
reaction.  MnCl2 can also be added to stabilize non-complementary pairs and decrease 
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the fidelity of Taq polymerase (10).   Mutation frequencies can be adjusted by varying 
the concentration of MnCl2 and the template gene, or adjusting the number of PCR 
cycles (11). 
DNA shuffling is a method for in vitro homologous recombination of pools of 
selected mutant genes.   The selected genes are randomly fragmented by DNase I, and 
fragments of the desired size are purified from an agarose gel.  These oligonucleotide 
fragments are reassembled into full length sequences by primerless PCR using cycles of 
denaturation, annealing, and extension by a DNA polymerase (Figure 1.2).  Following 
this reassembly reaction, the full length gene is amplified by PCR with upstream and 
downstream primers (12).  In addition, the recombination of a set of naturally occurring 
homologous genes is called “family shuffling”, which is also a very powerful approach 
for in vitro protein evolution.  The recombination of genes exploits the same parental 
gene or similar parental genes with higher than 80% identity.  However, Joern and 
coworkers have successfully recombined parental genes with only 63% DNA sequence 
identity. Through these experiments they were able to create a much more diverse 
library (13).  
E. coli mutator strains employ the mutator plasmids which encode genes with 
genetic deficiencies in DNA proofreading and editing machinery. The most commonly 
occurring deficiencies involve mutations in the mutD, mutS, and mutT genes.  
Specifically, mutD mutations can hinder the 3’-5’ exonuclease activity of DNA 
polymerase III. Therefore the repair of incorrect bases is prevented (14).   This method 
can generate large and diverse plasmid libraries, and high-frequency mutagenesis 
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Figure 1.2  Scheme of DNA shuffling method. (12) (A) A pool of homologous gene 
with different mutations is fragmented by DNase I. (B) Certain sizes of gene fragments 
are collected.   (C) Reassembly of random fragments into full-length gene results in 
frequent template switching and recombination.  (D) A recombinant gene can be selected 
from the library based on the improved function. The selected recombinants can provide 
the starting point for another round of mutation and recombination.  
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may be required for faster evolutionary improvement.  However, the mutation rate can 
be difficult to control.  Thus, PCR-directed random mutagenesis must be continuously 
tested to monitor the relative number of mutations being introduced (15). 
The mutant libraries are created and cloned into an expression vector and 
transformed into microorganisms for protein expression.  Functionally improved mutant 
proteins can be identified through carefully designed screening or selection methods.  
Some examples of the strategies for library screening or selection include: low 
throughput microtiter-well assays, high throughput screening methods and genetic 
selections.  The low throughput microtiter-well assays are suitable for the screening of a 
few thousand clones.  This method normally relies on a quantitative chromogenic assay 
and in-well chemical lysis of cell cultures to release overexpressed protein into solution.  
The quantitative chromogenic assay can be directly assayed by following the formation 
of chromophoric products or indirectly assayed with coupling systems that release a 
chromophore that absorbs light in the visible range.   Take the example of the 
colorimetric dehydrogenase screen based on NAD(P)H generation.  The second enzyme 
in the pentose phosphate pathway, 6-phosphogluconate dehydrogenase (6PGDH) 
catalyzes the NADP-dependent transformation of 6-phosphogluconate to ribulose-5-
phosphate, producing NADPH and CO2 in the process.  The activity of 6PGDH (or other 
dehydrogenases) is commonly measured by following the production of NADPH at 340 
nm, an unsuitable approach for the screening in cell lysates.  Because cell lysates have a 
moderate absorbance at 340 nm, the background absorbance of 96-well plates tends to 
be high in the UV-range, and reproducibility of measurements is low.  The colorimetric 
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alternative uses nitroblue tetrazolium (NBT), in the presence of phenazine methosulfate 
(PMS), it reacts with the NAD(P)H produced by dehydrogenases to produce an insoluble 
blue-purple formazan that is detectable at 580 nm (16)  (Scheme 1.1).  
Scheme 1.1  Colorimetric assay for 6PGDH activity.  
6PG                 NAD(P)+                        formazan (580 nm) 
6PGDH  
Rul-5p                 NAD(P)H               Nitroblue tetrazolium 
                  CO2 
         High-throughput screening methods have been widely used and developed.   The 
phage display method is a commonly used technique for the study of protein-protein, 
protein-peptide, protein-DNA, and protein-small molecule interactions.  It utilizes 
bacteriophages to connect proteins with the genetic information that encodes them.  The 
connection between genotype and phenotype enables large libraries of proteins to be 
screened and amplified (17).  Individual phages are selected through interaction of the 
displayed protein with ligands, and the specific phage is amplified by infection of 
bacteria (Figure 1.3 (A)).  Similar biological display approaches such as bacterial 
display, and yeast display have many advantages over the others.  However, the library 
size for these in vivo display systems is limited by the transformation efficiency of each 
organism.  For example, the library size for phage and bacterial display is limited to  
~ 109 different members. The library size for yeast display is even smaller.  In contrast, 
mRNA display is an in vitro display system, allowing a library size as large as 1015 
different members.  The large library size improves the diversity of the sequences and 
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increases the probability to select very rare sequences.  In addition, in vitro display 
methods remove unwanted selection pressure such as poor protein expression and rapid 
protein degradation, which may reduce the diversity of the selected variants (18).   The 
mRNA display technique uses translated peptides or proteins associated with their 
mRNA progenitor via a puromycin linkage, and the mRNA- protein fusion is bound to 
an immobilized target in a selection step. The mRNA-protein fusions that bind well to 
the target are then reverse transcribed to cDNA and their sequence amplified via a PCR.  
The nucleotide sequence with high affinity for the target molecule is then identified 
(Figure 1.3 (B)).   
     The display techniques described in the previous paragraph are generally used for 
screening ligands with high affinity for the proteins. One of the methods that efficiently 
isolates enzymatic activity from very large repertoires of protein variants, displays 
enzyme variants on filamentous phage. The reaction substrates and products are 
anchored on the calmodulin-tagged phage enzymes by a calmodulin binding peptide.  
Phages displaying catalytically active proteins are physically isolated by means of 
affinity reagents specific for the products of reactions (Figure 1.4) (19).   
            A couple of methodologies have been developed as in vivo selections, such as the 
protein fusion with chloramphenicol acetyltransferase (CAT) and the metabolic 
engineering of microorganisms.   The low solubility of a protein is one of the most 
frequent impediments for structural and functional analysis.  An approach to overcome 
this problem is to fuse target protein variants to a reporter protein whose activity will 
depend on the solubility and stability of the protein of choice.  The fusion of 
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chloramphenicol acetyltransferase (CAT) and the target protein variants is able to select 
the soluble mutants by visualizing the growth of the colonies on the agarose plate with 
chloramphenicol as the antibiotic.  This phenomenon depends on a correlation between 
the solubility of the protein and the ability of E. coli to grow on chloramphenicol (20).  
The other strategy for in vivo selection involves metabolic engineering of 
microorganisms. This technique normally depletes the sole carbon or phosphorus source 
required for cell growth and develops new carbon or phosphorus assimilation pathways.  
Sugiyama and coworkers developed the endogenous E. coli L-rhamnose pathway that 
was supplemented with L-rhamnose as a carbon source.   L-rhamnose, is actively 
incorporated into E. coli, which is first isomerized to the corresponding ketose, L-
rhamnulose, by L-rhamonose isomerase (RhaA).  Next, the phosphorylation of -
rhamnulose by rhamnulose kinase (RhaB) produces L-rhamnulose-1-phosphate, the 
natural substrate of RhaD.  RhaD cleaves rhamnulose-1-P by a retroaldol reaction into 
two three-carbon carbohydrates, dihydroxyacetone phosphate (DHAP) and L-
lactaldehyde, which are then metabolized through glycolysis or the TCA cycle.  Since 
the wild-type RhaD cannot cleave L-rhamnulose, the disruption of the rhamnulose kinase 
gene (rhaB-) leads to an inability to grow on minimal media supplemented with L-
rhamnose as a carbon source.  The newly evolved RhaD variants selected from the in 
vivo selection are capable of accepting unphosphorylated L-rhamnulose, which gives 
them the ability to survive on the carbon free minimum medium (Figure 1.5 (A)).  The 
E. coli strains lacking all of the rhaBAD genes were co-expressed with the RhaA gene  
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Figure 1.3  (A) Scheme of cycle of phage display method (17). (B) Scheme of cycle of 
mRNA display method (18, 21).  
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Figure 1.4  Calmodulin-tagged phage enzyme for the isolation of enzymatic activity.  
(19) 
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and the library of RhaD gene on a plasmid (Figure 1.5 (B)), the selected RhaD mutant 
was able to utilize L-rhamnulose as a sole carbon source (22). 
 
The Structural and Catalytic Relations within the Amidohydrolase Superfamily 
           Enzymes in the amidohydrolase superfamily (AHS) catalyze hydrolytic, 
decarboxylation, isomerization and hydration reactions within carbohydrate, nucleic acid 
and amino acid based substrates (1).  Most of the structurally characterized enzymes of 
the AHS contain either a binuclear or mononuclear metal center embedded at the C-
terminal end of a (β/α)8 barrel structural domain.  The first three enzymes identified in 
the AHS were urease (URE), phosphotriesterase (PTE), and adenosine deaminase 
(ADA).  Holm and Sander discovered the three-dimensional structural similarities within 
the active site and global protein folds in 1997.  Currently, there are approximately 40 
members of AHS that have been structurally characterized by X-ray crystallography.  
The metal centers of these enzymes are naturally populated by zinc, iron or nickel. Some 
members of the AHS are also active with manganese, cobalt, or cadmium (23, 24).   
There are eight structurally characterized variations of the divalent metal centers within 
the AHS.  The most common metal center is the binuclear metal center found in 
phosphotriesterase (PTE), dihydroorotase (DHO), iso-apspartyl dipeptidase (IAD), 
urease (URE), and the three types of hydantoinases (HYD).   The two divalent cations 
are approximately 3.6 Å apart and are ligated to the protein through electrostatic 
interactions with the side chains of six amino acids.  The more buried metal ion, Mα , is 
coordinated to two histidine residues from strand 1 of the β– barrel and an aspartate from  
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Figure 1.5 (A) Directed evolution of RhaD to alter its substrate specificity. (B) 
Metabolic engineering of E. coli rhamnose pathway for in vivo selection development 
(22).   
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strand 8; the more solvent exposed metal ion, Mβ , is associated with another two 
histidine residues from strands 5 and 6.  The two divalent cations are bridged by a 
hydroxide ion and a carboxylated lysine from strand 4 (Figure 1.6).  Some other 
subtypes of AHS have single divalent cations at the Mα or Mβ site, the glutamate residue 
from strands 3 or 4 replaces the carboxylated lysine from strand 4, or one cysteine 
residue from strand 2 serves as the metal-associated ligand.   
            The catalytic reactions of enzymes in the AHS are generally hydrolytic reactions 
with some exceptions, such as uronate isomerase (URI) and α-amino-β-
carboxymuconate-ε-semialdehyde decarboxylase (ACMSD). The former catalyzes an 
aldose/ketose isomerization reaction between D-glucuronate and D-fructuronate and the 
later catalyzes  a decarboxylation reaction that transforms α-amino-β-carboxymuconate-
ε-semialdehyde (ACMS) to 2-aminomuconate semialdehyde (AMS) and carbon dioxide 
(25, 26).  PTE catalyzes the hydrolysis of phosphorus-oxygen or phosphorus-sulfur 
bonds within an organophosphate or organophosphonate compounds.  The rest of the 
structurally characterized enzymes catalyze the cleavage of C-N bonds.  Scheme 1.2 
displays the chemical reactions catalyzed by enzymes in the AHS.   
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Figure 1.6  Schematic view of the most common metal center, binuclear metal centers 
of enzymes, in the amidohydrolase superfamily.  The member with this active site 
representation is exemplified by PTE.  
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Scheme 1.2  The chemical reactions catalyzed by the enzymes in amidohydrolase 
superfamily. 
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Scheme 1.2 Continued 
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Scheme 1.2 Continued 
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Scheme 1.2 Continued 
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Directed Evolution of the Enzymes in the Amidohydrolase Superfamily 
            Most of the reported directed enzyme evolution studies in the amidohydrolase 
superfamily have been focused on phosphotriesterase.  Wilfred Chen and coworkers 
have engineered PTE for the enhancement of the hydrolysis activity towards 
organophosphate pesticides such as paraoxon, parathion, methyl parathion and 
chlorpyrifos (Scheme 1.3) (27, 28).  They created the randomized library of PTE by 
DNA shuffling and saturation mutagenesis, and subcloned it into INPNC surface display 
vector, pINCOP.  The library was transformed into E. coli XL1-Blue cells and PTE 
variants were displayed on the surface of the cells using the truncated ice nucleation 
protein.  The beneficial PTE variants were isolated by solid-phase top agar plate assay 
based on the formation of yellow products (p-nitrophenol) and clear haloes (the product 
of chlorpyifos).  The best improvement they have achieved was that the variant, B3561, 
exhibited a 725-fold increase in the kcat/Km value for the chlorpyrifos hydrolysis.  This 
mutant involves 8 amino acid substitutions and 7 of them are distal mutations from the 
active site (27, 28).   
Scheme 1.3  The structures of paraoxon, parathion, methyl parathion and chlorpyrifos. 
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             James Wild and colleagues have modified the amino acid residues within the 
substrate binding pocket of PTE for the hydrolysis of paraoxon, p-nitrophenyl-o-
pinacolyl-methylphosphonate (NPPMP), diisopropyl fluorophosphonate (DFP) and 
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dementon-S (Scheme 1.4) (29, 30).  These experiments served as the model for the P-O 
bond, P-F bond and P-S bond cleavage of the organophosphate compounds.  Saturation 
mutagenesis was performed and the H254R/H257L mutant was identified with a 6 fold 
enhancement in the kcat/Km value toward dementon-S (29).  In addition, the H257L and 
the H254R/H257L mutants were shown to have an 11 and 18 fold increase in the kcat/Km 
values toward NPPMP (an analogue of nerve agent soman) respectively.  In contrast, the 
H254R, the H257L and the H254R/H257L mutants showed a substantial decrease in the 
catalytic ability towards the hydrolysis of DFP (30).  
Scheme 1.4  The structures of paraoxon, p-Nitrophenyl-o-pinacolyl-methylphosphonate 
(NPPMP), diisopropyl fluorophosphonate (DFP) and dementon-S. 
 
David Ollis and coworkers have also modified the phosphotriesterase from 
Agrobacterium radiobacter P230 (OpdA), which has a 90% sequence identity to PTE 
(31, 32).  They discovered the engineered OpdA variants with the enhanced protein 
expression levels and increased catalytic activity for the hydrolysis of organophosphate 
compounds, such as coumaphos-o-analogue, methyl-paraoxon, methyl-parathion and 
demeton-S (Scheme 1.5).  They created OpdA and PTE libraries by error-prone PCR 
and DNA shuffling, and cloned the library into E. coli cells.  They isolated the beneficial 
mutants for the hydrolysis of paraoxon and the increased protein expression levels by 
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growing the library on the paraoxon plates and selecting the largest colonies.  They also 
grew the cells with the constructed library on indicator plates.  The isolation of 
interesting mutants is done by visualizing the colonies with significant fluorescence. 
They have identified some distal mutations that improve protein expression and stability.  
In addition, PTE variants isolated from the indicator plates, exhibited slightly better 
activity for the hydrolysis of coumaphos-o-analogue, methyl-paraoxon, methyl-parathion 
and demeton-S than the wild-type PTE but not the wild-type OpdA.   These two 
selection methodologies have selected the OpdA and the PTE variants with some 
mutations that are remote from the active site, these changes might affect the dynamics 
and stability of the protein in a way that improves the substrate binding or subsequent 
catalytic turnover (31, 32). 
Scheme 1.5  The structures of coumaphos-o-analogue, methyl-paraoxon, methyl-
parathion and dementon-S.   
 
Dan Tawfik and collaborators have worked on directed evolution of PTE for 
increasing the stability of the metal-free enzyme and the hydrolysis activity towards 
paraoxon (33, 34).  The randomized library was created by DNA shuffling and the PTE 
library was screened for improvements in 2-naphthyl acetate (Scheme 1.6) hydrolysis.  
E. coli DH5α cells was transformed with the PTE library and plated on zinc containing 
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LB plate.  After growing colonies overnight, a layer of soft agar supplemented with 2-
naphthyl acetate and Fast Red was added.  The colonies that turned red first were 
selected for further screening for the hydrolysis of paraoxon and 2-naphthyl acetate.  
Through this method, they have isolated a variant called S5, which contains 3 point 
mutations, K185R, D208G, and R319S and 4 additional silent mutations. This protein 
has a 20 fold increase in functional expression (33).  Additionally, they employed in 
vitro compartmentalization (IVC) based on linking genotype and phenotype to select the 
beneficial mutants for thy hydrolysis of paraoxon.  The PTE mutant library was 
constructed and selected for the catalysis of paraoxon by compartmentalization using 
water-in-oil emulsions.  The PTE library was linked to streptavidin-coated beads 
carrying antibodies through a common epitope tag, the average was less than one gene 
per bead.  The beads were compartmentalized in a water-in-oil emulsion, and it was less 
than one bead per compartment.  The translated protein became attached to the gene that 
encodes it via the bead in each compartment. After the emulsion was broken, the 
microbeads carrying the display library were isolated. (Figure 1.7 (A))  The microbead-
display library was compartmentalized and the substrate, paraoxon, attached to caged-
biotin was added.  The product was produced only in compartments containing beads 
displaying active enzyme.  The emulsion was then irradiated to uncage the biotin.  In the 
compartments with the active PTE variants, the product became attached to the gene via 
the bead. In contrast, the compartments with the genes encode the non-active PTE 
variants contain the intact substrate attached to the gene.  The emulsion was broken and 
the beads were incubated with the anti-product antibody. The product-coated beads were 
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purified by flow cytometry (Figure 1.7 (B)).  Through this method, the best variant they 
have discovered was the I106T/F132L PTE mutant with two mutations within the active 
site, the kcat and the kcat/Km values are 63 and 1.8 times higher than the wild-type for the 
hydrolysis of paraoxon.  The kcat value of this mutant is 1.4 x 105 s-1 (34).  
Scheme 1.6  The structure of 2-naphthyl acetate. 
                                
            Hydantoinase is another enzyme in the amidohydrolase superfamily that has been 
engineered to invert the enantioselectivity (35).  The selectivity of all known 
hydantoinases for D-5-(methylthioethyl)hydantoin (D-MTEH) over the L-enantiomer 
leads to the accumulation of intermediates and reduced the productivity for the L-amino 
acid (Scheme 1.7).  Error prone PCR was performed to create a randomized library of 
hydantoinases from Arthrobacter sp. DSM 9711.  The library was screened by D-MTEH 
and L-MTEH in the presence of cresol red solution and measured the absorbance at 580 
nm.  With the combination of the saturation mutagenesis, they discovered three 
mutations containing variant of D-selective hydantoinase that converts into an L-
selective enzyme and increased total activity for 5 fold.  A mutant with single amino 
acid substitution was found as a highly D-selective hydantoinase.  
Scheme 1.7  The structure of the L- the D-enantiomers of methylthioethyl hydantoin.  
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Figure 1.7  Creation of microbead-display PTE libraries and selection for catalysis by 
compartmentalization (34). 
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Three Dimensional Structure of Phosphotriesterase  
The X-ray crystal structure demonstrates that PTE contains a binuclear metal 
center embedded within a (/)8 barrel structure.  The binuclear metal center is located 
at the C-terminal end of -barrel (Figure 1.8).  PTE is a homodimeric protein with a 
molecular weight of 36 kDa/monomer (36).  Native PTE contains two Zn 2+ ions in the 
metal center, but they can be reconstituted with Cd2+, Co2+, Ni2+, and Mn2+ without 
losing catalytic activity (37).  The two metals are bridged by a carboxylated lysine (Lys-
169) and a hydroxide ion. The more solvent-shielded metal (Mα) is coordinated to His-
55, His-57, and Asp-301, and the more solvent-exposed metal (Mβ) is coordinated to 
His-201 and His-230 (Figure 1.9).  Previous investigation based on the interaction 
between the phosphorus center of substrates and inhibitors defined the three binding 
pockets within the active site of PTE: a large pocket, a small pocket and the leaving 
group pocket (38).  The small pocket is defined by the side chains of Gly-60, Ile-106, 
Leu-303, and Ser-308; the large pocket is formed by His-254, His-257, Leu-271, and 
Met-317; the leaving group pocket is surrounded by four residues: Trp-131, Phe-132, 
Phe-306, and Tyr-309. The substrate binding site of PTE is graphically shown in Figure 
1.10. 
 
The Reaction Mechanism of Phosphotriesterase  
            The catalytic mechanism for the hydrolysis of organophosphate triesters by PTE 
has been studied.  The kinetic parameters and pH rate profiles of Zn/Zn PTE, Cd/Cd 
PTE, and a mixed-metal Zn/Cd hybrid PTE were obtained with various substrates to 
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Figure 1.8  The X-ray crystal structure of phosphotriesterase displaying a (/)8 TIM 
barrel. (PDB: 1HZY) 
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Figure 1.9  The zinc binuclear metal center of phosphotriesterase is shown with the 
bridged carboxylated lysine, hydroxide ion and the associated amino acid residues. 
(PDB: 1HZY) 
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Figure 1.10  Graphic representation of the substrate binding pockets within the active 
site of PTE.  The small pocket consists mainly of Gly-60, Ile-106, Leu-303, and Ser-308.  
The large pocket primarily contains His-254, His-257, Leu-271, and Met-317.  The 
leaving group pocket is surrounded by Trp-131, Phe-132, Phe-306, and Tyr-309 (37). 
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determine the role of the - and - metals in binding and catalysis.   The pH-rate profiles 
of the hybrid enzyme indicates that the - metal determines the pKa value for the 
bridging hydroxide ion (39).  This suggests that the hydrolytic nucleophile is activated as 
a hydroxide via the ionization of a water molecule coordinated to the - metal ion.   In 
addition, EPR spectroscopy of the complex of Mn/Mn-PTE and substrate analogues 
supports the weakening of the interaction of the bridging hydroxide with the –metal ion 
(40).  Mutational studies at Asp-301 indicate the reactivity of the bridging hydroxide ion 
is enhanced by proton transfer to Asp-301 (39, 41).  A nucleophilic attack of the 
activated hydroxide ion at the phosphorus center occurs with the expulsion of the leaving 
group.  The slightly modified reaction mechanism, originally proposed by Aubert et al., 
for the hydrolysis of paraoxon by PTE from P. diminuta is presented in Figure 1.11.  
The organophosphate substrate binds to the binuclear active site with a water molecule 
displaced from the β-metal ion.  The interaction of the substrate with the β–metal ion 
weakens the coordination of the bridging hydroxide ion to the β–metal ion.  It also 
assists in the nucleophilic attack of the hydroxide on the phosphorus center of the 
substrate via an SN2-like mechanism. The stereochemistry at the phosphorus center of 
the substrate is inverted by this attack.  The P-O bond of the leaving group phenol is 
broken, and the single proton from the nuceophilic hydroxide is transferred to Asp-301.  
The diethylphosphate is bridged between the two divalent cations within the active site.  
The diethyl phosphate then disassociates from the active site, following the regeneration 
of the binuclear metal center for another round of catalysis.   
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            Two other proposed mechanism for the hydrolysis of phosphotriesters by 
bacterial PTE were proposed by Jiali Gao’s and David Ollis’s laboratories (41, 42).  
Wong and Gao have proposed that the protonated diethyl phosphate coordinates to the 
–metal ion and follows by an elongation of the metal-metal distance from 3.6 to 5.3Å. 
At the same time, the reaction proceeds from an enzyme-substrate complex to an 
enzyme-transition state complex and an enzyme-product complex (Figure 1.12 (A)) 
(41). Additionally, Jackson and coworkers from David Ollis’s laboratory have postulated 
that the other reaction mechanism of the hydrolysis of phosphotriesters by a bacterial 
PTE from Agrobacterium radiobacter, OpdA.  They suggested that the bridging 
hydroxide acts as a base, instead of acting as a nucleophile, in the abstraction of proton 
from a water molecule.  The water molecule terminally bound to the α-metal ion 
becomes a hydroxide nucleophile to attack the electrophilic phosphorus atom of the 
substrate.   After departure of the leaving group, the phosphodiester bridges two metal 
ions (Figure 1.12 (B)) (42).  
 
Substrate Specificity of Phosphotriesterase 
            PTE has a significant activity for the hydrolysis of paraoxon and possess very 
broad substrate specificity for organophosphates, organophosphonates, 
organophosphinates, thiophosphates and phosphorothiolates.   PTE exhibits very 
different catalytic ability with varied pKas of the leaving group.  It has been shown that 
the rate limiting step is dependent on the bond cleavage of the leaving groups with high 
pKa values (43).  In addition, the previous kinetic studies of the catalytic ability of 
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Figure 1.11  The proposed mechanism of the hydrolysis of paraoxon by PTE. The pink 
balls ( ) represent zinc metal. 
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Figure 1.12  (A) Wong and Gao’s proposed reaction mechanism of the hydrolysis of 
paraoxon by PTE from P. diminuta (41). (B) Jackson and Ollis’s proposed mechanism 
of the hydrolysis of phosphotriesters by OpdA from Agrobacterium radiobacte (42).  
The pink balls ( ) represent zinc metal. 
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the wild-type PTE towards a series of enantiomeric organophosphate triesters (Scheme 
1.8) were shown that the Sp– enantiomers are more preferable than the Rp– enantiomers.   
In the case of methyl phenyl p-nitrophenyl phosphate (X and Y are phenyl and methyl 
groups), the hydrolysis of the Sp– enantiomer is 90 fold faster than the Rp– enantiomer 
by the wild-type PTE (44).   
Scheme 1.8  The model of organophosphate triesters. 
P
O
O O
O
X Y
NO2  
The stereoselective properties of the wild-type PTE toward chiral sarin and 
soman analogues have also been studied.  The structures of the organophosphonate 
compounds sarin, soman and their analogues are shown in Scheme 1.9.  Previous 
investigations have shown that the wild-type PTE is more efficient at hydrolyzing the 
Rp– enantiomer of the sarin analogue than the Sp– enantiomer by a factor of 20.  The 
hydrolysis of the soman analogue by the wild-type PTE have been shown that RpRc- 
enantiomer is the most preferable isomer, with the order of the preference being RpRc, 
RpSc, SpRc, SpSc.  A small numbers of mutations within the substrate binding pocket of 
PTE are able to enhance and reverse the stereoselectivity exhibited by wild-type PTE 
(45). 
 
                                                                                             
37
Scheme 1.9  The structures of sarin, soman and their analogues. 
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History of Organophosphate Compounds 
            Organophosphorus compounds (OP) are currently used as insecticides and 
chemical warfare agents.  Organophosphates have been used as pesticides for more than 
50 years and are still being used as insecticides, acaricides, and nematocides for 
protecting agricultural crops.  One of the earliest OP insecticides synthesized was 
parathion (Scheme 1.10), which is still commonly used worldwide.  Prior to World War 
II, the German Ministry of Defense started shifting from insecticides to chemical warfare 
agents.  First, they synthesized diisopropyl phosphorofluoridate (DFP) and then 
developed more toxic OP compounds of the G series (tabun, sarin, and soman).  Tabun 
(GA) was the first compound synthesized by the German scientist Schrader in a search 
for an efficient pesticide.  He then developed the second nerve agent, sarin (GB), in 
1938.  The other G series nerve agent, soman (GD), was synthesized by Richard Kuhn, 
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in 1944 during World War II.  Cyclosarin (GF) was developed by Schrader in 1949.  A 
few years later, the most toxic of the reported nerve agents, VX, was synthesized by 
Ranajit Ghosh, who worked at the CW facility in Porton Down, England in 1952.  The 
British government traded the VX technology with the USA for continuing with sarin as 
the UK chemical weapon in 1958.  The US Army then went into production of large 
amounts of VX in 1961 at Newport Chemical Depot. The VX stockpile there has been 
completely destroyed since August 2008. One of the most well-known uses of the nerve 
agents was the 1995 terrorist attack in Japan. One of the Japanese religious groups 
released sarin into the Tokyo subway system.  
Scheme 1.10  The chemical structures of common organophosphate insecticides and 
nerve agents.  
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Toxicity of Organophosphate Compounds and Inactivation of Acetylcholinesterase 
            The toxicity of the organophosphorus compounds is due to the inactivation of 
acetylcholinesterase (AChE), the enzyme that catalyzes the hydrolysis of acetylcholine 
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to choline and acetic acid at neural synapses.  The hydrolysis of acetylcholine (ACh) is 
initiated by the nucleophilic attack of Ser-200 on the carbonyl center to form an 
acetylated AChE and release the first product, choline. The free AChE is then 
regenerated by the hydrolysis of the acetylated AChE complex and the second product, 
acetic acid, is released (Figure 1.13 (A)). The inhibition of AChE by organophosphates 
results from the phosphorylation of the active site residue Ser-200 of AChE that forms a 
phosphorylated enzyme intermediate.  In this case, the hydrolysis ability of ACh is very 
slow. Thus, the accumulation of ACh at the synapse causes the paralysis of the 
cholinergic synaptic transmission (46). The phosphorylated AChE can be reactivated 
by an oxime nucleophile such as 2-PAM. However, if the oxime nucleophile is not 
used, the phosphorylated AChE can undergo a base-assisted dealkylation reaction, called 
“aging”, which result in irreversible enzyme inhibition (47).  
            The toxicity of organophosphate nerve agents is dependent on the 
stereochemistry of the phosphorus chiral center.  Tabun, sarin, cyclosarin, and VX have 
two stereoisomers due to a single chiral center at the phosphorus atom, while soman has 
four stereoisomers due to an additional chiral center within the pinacolyl substituent.  
The inhibitory studies of acethylcholinesterase (AChE) determined that the Sp-
stereoisomer of sarin is approximately ~104 times more toxic than the Rp-stereoisomer. It 
has been shown that the Sp-stereoisomer of soman is ~105 times more toxic than the Rp- 
stereoisomer.  Similarly, the Sp-stereoisomer of VX is 100-fold more toxic than the Rp-
stereoisomer. VX is the most toxic compound among all organophosphate nerve agents. 
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Figure 1.13  (A) The hydrolysis of acetylcholine (ACh) by acetylcholinesterase(AChE). 
(B) The reactivation of phosphorylated acetylcholinesterase by oxime nucleophile and 
the formation of an “aged” AChE without reactivation.  
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Table 1.1 displays the toxicity of individual stereoisomer of sarin, soman and VX in 
terms of LD50 values for mice and the inhibition rate constants for AChE (48).   
 
Other Organophosphate Hydrolyzing Enzymes 
There are other enzymes with the ability to detoxify organophosphate 
compounds, such as human paraoxonase 1 (PON1), squid DFPase and 
organophosphorus acid anhydrolase (OPAA).  The comparison of the catalytic ability of 
these organophosphate hydrolyzing enzymes and PTE for the hydrolysis of 
organophosphate insecticides and chemical warfare agents are shown in Table 1.2.  
DFPase was isolated from the optical ganglion of Loligo vulgaris.  The X-ray 
crystal structure of DFPase shows two calcium ions are present, one is essential for 
structural integrity and the other is crucial for catalysis.  The overall structure of DFPase 
is a six bladed pseudosymmetrical β-propeller with a central water filled tunnel (49).  It 
was shown to be able to hydrolyze tabun, sarin, soman, cyclosarin and diisopropyl 
flurophosphates.  The activity for the hydrolysis of  diisopropyl fluorophosphates (DFP) 
is high, with a kcat of 526 s-1 and a kcat/Km of 1.3 x 106 M-1 s-1, but the activities for GA, 
GB and GD are 3 to 4 times lower (50, 51). 
            Human serum paraoxonase (HuPON1) is a calcium-dependent enzyme.  The 
amino acid sequence alignments and the X-ray crystal structures of HuPON1 and 
DFPase have shown that these two protein share similar structures in which six blade-
like regions of β– pleated sheets are arranged radially around a central core.  HuPON1  
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Table 1.1  Inhibition rate constants of the nerve agent stereoisomers on AChE (48). 
Nerve Agent 
Stereoisomer 
LD50 (Mouse) μg/Kg Inhibition Rate Constant 
 (M-1min-1) 
Rp-Sarin 
Sp-Sarin 
RpRc-Soman 
RpSc-Soman 
SpRc-Soman 
SpSc-Soman 
Rp-VX 
Sp-VX 
 
41 
>5000 
>2000 
99 
38 
165 
12.6 
< 3 x 103 
1.4 x 107 
<5 x 103 
<5 x 103 
2.8 x 108 
1.8 x 108 
2 x 106 
4 x 108 
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Table 1.2  The kinetic parameters of organophosphate hydrolyzing enzymes toward the 
organophosphate insecticide and chemical warfare agents (54-59).  
 DFPase HuPON1 OPAA PTE  
 
kcat 
(s-1) 
kcat/Km 
(M-1 s-1) 
kcat 
(s-1) 
kcat/Km 
(M-1 s-1) 
kcat 
(s-1) 
kcat/Km 
(M-1 s-1) 
kcat 
(s-1) 
kcat/Km 
(M-1 s-1) 
Paraoxon    1.1e4   1.0e4 1.0e8 
DFP 5.3e2 1.3e6  6.2e2 1.7e3  2.2e2 1.0e7 
Tabun (GA)     8.5e1  7.7e1 7.6e5 
Sarin (GB) 1.8e2   1.5e4 6.1e2  5.6e1 8.0e4 
Soman (GD) 3.2e2 4.0e1  4.7e4 3.1e3  4.8e0 1.0e4 
Cyclosarin (GF)  8.5e1   1.7e3  3.0e-2  
VX   1.8e0 7.2e2   3.0e-1 7.0e2 
Dementon-S       1.0e0 3.8e2 
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possesses the catalytic ability to hydrolyze esters, including lactones and 
organophosphates compounds. Yet, the catalytic activity to hydrolyze GB, GD, and VX 
is low (52).  
  Organophosphorus acid anhydrolase (OPAA) from Alteromonas sp. JD6.5 is 
also capable of catalytically hydrolyzing a wide variety of organophosphoate 
compounds, including GB, GD and GF.  However, VX is not a substrate for OPAA.  
The sequence and biochemical analysis of OPAA suggested it naturally functions as a 
prolidase, a type of dipeptidase hydrolyzing dipeptides with a proline residue in the 
carboxyl-terminal position (X-Pro). The stereochemical preference of OPAA is similar 
to PTE.  OPAA has higher catalytic ability for the hydrolysis the Rp- stereoisomers of 
sarin and soman analogues (53).   
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CHAPTER II 
PRODUCT COMPLEX WITH THE BINUCLEAR METAL CENTERS FROM 
THE AMIDOHYDROLASE SUPERFAMILY OF ENZYMES* 
 
Introduction 
The amidohydrolase superfamily (AHS) of enzymes catalyzes hydrolytic, 
decarboxylation, isomerization, and hydration reactions within carbohydrate, nucleic 
acid and amino acid based substrates (23).  Most of the structurally characterized 
enzymes of the AHS contain either a binuclear or mononuclear metal center embedded 
at the C-terminal end of a (β/α)8-barrel structural domain.  For those enzymes that 
catalyze hydrolytic reactions the metal centers have been shown to activate solvent water 
for nucleophilic attack.  High resolution x-ray structures have been obtained for 
approximately 20 members of the AHS and in these enzymes the metal centers are 
naturally populated by zinc, iron or nickel (23).  In addition, some members of the AHS 
are also active with manganese, cobalt, or cadmium (24).  Perhaps the best characterized 
member of the amidohydrolase superfamily is the bacterial phosphotriesterase from 
Pseudomonas diminuta (60). 
Phosphotriesterase (PTE) catalyzes the hydrolysis of a wide range of 
organophosphate esters, including agricultural pesticides and highly toxic chemical 
 
______________ 
*Reprinted with permission from “Structure of Diethyl Phosphate Bound to the 
Binuclear Metal Center of Phosphotriesterase” by Jungwook Kim, Ping-Chuan Tsai, 
Shi-Lu Chen, Fahmi Himo, Steven C. Almo and Frank M. Raushel, 2008. Biochemistry, 
47, 9497-9504, Copyright 2008 by the American Chemical Society. 
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warfare agents (60-62).  A natural substrate for PTE is not known, however, the purified 
PTE exhibits a remarkable catalytic activity towards the hydrolysis of the commercial 
pesticide, paraoxon.  Kinetic constants for kcat and kcat/Km of 104 s-1 and 108 M-1 s-1, 
respectively, have been measured for the hydrolysis of this substrate (63-65).  The 
reaction for the hydrolysis of paraoxon is presented in Scheme 2.1.  The enzyme has 
been crystallized and high resolution x-ray structures of the Zn/Zn-, Cd/Cd-, Mn/Mn- 
and the Zn/Cd-PTE hybrid have been solved (24).  Shown in Figure 2.1 is the 
coordination scheme for the binuclear metal center of Cd/Cd-PTE.  The more solvent 
shielded metal (Mα) is coordinated to His-55, His-57, and Asp-301, whereas the more 
solved-exposed metal (M) is coordinated to His-201, His-230 and two water molecules 
from solvent.  The two metals are bridged to one another by a carboxylated lysine (Lys-
169) and hydroxide.  The bridging hydroxide is additionally hydrogen bonded to the side 
chain carboxylate of Asp-301.  
Scheme 2.1 The reaction for the hydrolysis of paraoxon by phosphotriesterase. 
 
 
 
 
 
The reaction mechanism for the hydrolysis of organophosphate triesters by 
phosphotriesterase has received considerable experimental and computational attention 
(39, 41, 42, 66). Presented in Scheme 2.2 is a slightly modified reaction mechanism,  
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Figure 2.1  Model for the structure of the binuclear metal center within the active site of 
Cd/Cd-PTE (24).  The coordinates taken from PDB code: 1JGM.  The two metal ions are 
depicted as light brown spheres.  
                                                                                             
48
originally proposed by Aubert et al., for the hydrolysis of paraoxon by the 
phosphotriesterase from P. diminuta (39).  In this mechanism the organophosphate 
substrate binds to the active site with the displacement of a water molecule from the β-
metal ion.  The interaction of the substrate with the β-metal ion weakens the 
coordination of the bridging hydroxide to the β-metal ion and facilitates the nucleophilic 
attack of the hydroxide in an SN2-like reaction on the phosphorus center of the substrate.  
The bond to the leaving group phenol is broken and the single proton from the 
nucleophilic hydroxide is transferred to Asp-301.  The anionic diethyl phosphate is 
bound within the active site as a bridging ligand between the two divalent cations.  The  
diethyl phosphate dissociates from the active site and the binuclear metal center is 
subsequently recharged for another round of catalysis.   
Experimental evidence for the direct interaction of the substrate with the β-metal 
ion comes from the x-ray structure of PTE bound with a diisopropyl methyl phosphonate 
inhibitor (PDB code 1EZ2) and the differential effects on the kinetic constants for the 
hydrolysis of phosphate and thiophosphate esters with zinc and cadmium substituted 
variants of PTE (39).  Support for the weakening of the interaction of the bridging 
hydroxide with the β-metal ion is derived from the loss of antiferromagnetic coupling 
between the two metal ions in Mn/Mn-PTE upon binding of substrate analogues using 
EPR spectroscopy (40).  The utilization of the hydroxide that is bridging the two metal 
ions as the direct nucleophile is supported by the observation that in the presence of 
substrate analogues there are no other water molecules bound to either of the two metal 
ions in Zn/Zn-PTE (PDB:3CAK). 
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General support for the reaction mechanism of Scheme 2.2 was also provided by 
recent density functional theory (DFT) calculations by Chen et al (66). A model of the 
PTE active site was devised based on the crystal structure of the wild-type Zn/Zn-
enzyme (PDB code 1HZY). The calculations showed that the bridging hydroxide is 
sufficiently nucleophilic to attack the phosphorus center of organophosphate triester 
substrates. The barrier for the nucleophilic attack was calculated to be very feasible.  
Recently, two provocative modifications to the mechanism presented in Scheme 
2.2 have been proposed (41, 42).  In a computational assessment of the PTE reaction 
mechanism, Wong and Gao have postulated a mononuclear coordination scheme of 
protonated diethyl phosphate to the β-metal ion that is coupled with a lengthening of the 
metal-metal distance from 3.6 Å to 5.3 Å as the reaction proceeds from an enzyme-
substrate complex to an enzyme-product complex (41).  A representation of this product 
complex is provided in Scheme 2.3.  In addition, Ollis and colleagues have proposed 
that the bridging hydroxide acts not as a nucleophile but as a base in the abstraction of a 
proton from a water molecule that is apparently loosely coordinated to the α-metal ion.  
The chemical mechanism and product complex proposed by Ollis and colleagues are 
illustrated in Scheme 2.3 (42).  Experimental support for this proposal derives primarily 
from an x-ray structure of a dimethyl thiophosphate complex of the PTE from 
Agrobacterium radiobacter and catalytic properties of model complexes that are 
purported to mimic the active site of PTE (67). 
           In this investigation, the structure of diethylphosphate bound to the active site of 
PTE was probed by X-ray diffraction techniques.  This structure has been used to help 
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Scheme 2.2  The proposed mechanism of the hydrolysis of paraoxon by bacterial 
phosphotriesterase.  The pink balls ( ) represent zinc metal. 
 
Scheme 2.3  Wong and Gao’s and Ollis’s proposed reaction mechanisms of the 
hydrolysis of organophosphotriesters by phosphotriesterase (41, 42).  The pink balls ( ) 
represent zinc metal. 
 
differentiate among the three mechanistic possibilities for the hydrolysis of 
organophosphate esters by PTE. In addition, we have performed DFT calculations to 
assess the energetic feasibility of the base mechanism proposed by Ollis and co-workers. 
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Materials and Methods 
Purification of Wild-Type and G60A Mutant.  The genes encoding the wild-type 
PTE (opd) and the G60A mutant were ligated between the NdeI and EcoRI sites of a 
pET20b (+) plasmid.  The wild-type and mutant plasmids were transformed into E. coli 
strain BL-21 cells (DE3) (64).  The transformed BL-21cells were inoculated in Luria-
Bertani (LB) broth overnight at 37 oC.  The overnight cultures were then incubated in 
Terrific Broth (TB) containing 100 μg/mL ampicillin and 1.0 mM CoCl2 at 30°C.  IPTG 
was added when the OD600 reached 0.4, followed by incubation for 36-42 hours at 30 °C 
to reach the stationary phase.  The cell paste was harvested by centrifugation at 4 °C.  
The wild-type PTE and G60A mutant were purified as previously described (39).  SDS-
polyacrylamide gel electrophoresis demonstrated that the wild-type PTE and the G60A 
mutant migrated with proteins having a molecular weight of ~36 kDa.  The purity was 
estimated to be greater than 95%.  
Measurement of Kinetic Constants.  The kinetic parameters were obtained by 
fitting the data to equation 1, where ν is the initial velocity, kcat is the turnover number, 
[A] is the substrate concentration, Et is the enzyme concentration, and Ka is the 
Michaelis constant.  The inhibition constants, Kii and Kis, for the noncompetitive 
inhibition of cacodylate in the presence of the substrate paraoxon, were determined by 
fitting the data to equation 2, where [I] is the concentration of inhibitor and the other 
constants have been defined previously.  The concentration of paraoxon was varied from 
0.05 mM to 2.5 mM.  Six different cacodylate concentrations were used in these assays, 
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ranging from 0 mM to 250 mM.  The rate was measured by following the change in 
absorbance at 400 nm.  
ν/Et = kcat [A] / (Km + [A])                                         (2.1) 
ν/Et = kcat [A]/(Km (1 + ([I]/ Kis)) +[A]( 1 + ([I]/ Kii)))                   (2.2) 
Synthesis of Diethyl Phosphate.  Diethyl phosphate was synthesized by Dr. 
Yingchun Li of Texas A&M University.  Diethyl phosphorochloridate was reacted with 
phenol in ethyl ether in the presence of triethylamine to yield diethyl phenyl phosphate 
after purification using silica gel chromatography.  Hydrogenation of the resulting 
organophosphate in methanol using Pd/C as a catalyst provided diethyl hydrogen 
phosphate quantitatively after separation of the catalyst by filtration and removal of the 
solvent by evaporation under reduced pressure(68). The identity and the purity (>98%) 
of the diethyl phosphate were confirmed by 1H and 31P NMR spectroscopy. 
X-ray Structure Determination and Refinement.  The G60A mutant was 
crystallized by hanging drop vapor diffusion at 21 oC by mixing 1 L of the protein with 1 
L of reservoir solution (0.2 M magnesium acetate, 0.1 M sodium cacodylate (pH 6.5), 
20% polyethylene glycol (PEG) 8000) and equilibrating over 1.0 mL of reservoir 
solution.  X-ray data were collected on a MAR CCD 165 mm detector at the NSLS X3A 
beam line, using x-ray wavelength at 0.97904 Å and processed with HKL2000 (69). The 
G60A crystal exhibited diffraction consistent with the space group P1 (a = 55.29 Å, b = 
68.30 Å and c = 90.03 Å).  There were four G60A molecules two homodimers of in the 
asymmetric unit.    
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The wild-type Co/Co-PTE was co-crystallized with 17 mM diethyl phosphate 
(DEP) in 0.1 M Bis-Tris (pH 6.5) and 20% PEG monomethyl ether 5000.  X-ray data 
were collected on an R-Axis IV++ image plate detector using CuKα radiation from a 
Rigaku RU-H3R X-ray generator and processed using HKL2000 (69).  The co-crystals 
of wild-type PTE with DEP exhibit diffraction consistent with space group P1 (a = 43.29 
Å, b = 45.34 Å and c = 78.91 Å).  Two protein molecules are observed in the 
asymmetric unit.   
The structures of G60A and wild-type PTE with bound DEP were determined by 
molecular replacement using program MOLREP using 1P6B and 2OB3 as initial search 
models, respectively (70).  Solvent water molecules were built using Arp/ wArp (71).  
All subsequent model building and refinement was carried out with Coot (72) and 
REFMAC5 (73).  The final models were refined to 1.95 and 1.83 Å with Rwork/Rfree of 
0.167/0.224 and 0.140/0.196, respectively (Table 2.1).  The crystallization, structure 
determination and refinement of the wild-type PTE and the G60A mutant were 
performed by Dr. Jungwook Kim from Albert Einstein College of Medicine.  
Computational Details.  All theoretical calculations were performed using the 
hybrid density functional theory (DFT) functional B3LYP (74-76). Geometry 
optimization were carried out with 6-31G(d,p) basis set for all elements except the Zn, 
for which the effective core potential LANL2DZ basis set was used. Based on these 
geometries, more accurate energies were obtained by performing single point 
calculations with the larger basis set 6-311+G(2d,2p) for all elements. Solvation effects 
were calculated at the same theory level as the optimizations by performing single point  
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Table 2.1  Data collection and refinement statistics 
 
______________________________________________________________________ 
Data collection                   G60A-cacodylate            wild-type PTE-DEP 
______________________________________________________________________ 
Resolution, Å                             31.64-1.95                   20.49-1.83 
Observed reflections                 270,828                        137,406 
Unique reflections      91,515                          47,158 
Completeness                          96.3(80.7)1                   93.2(81.8)1 
I/sigma                                         15.8 (3.4)1                   13.2 (3.0)1 
Rmerge2                        0.076(0.286)1              0.061(0.319)1 
_______________________________________________________________________
_ 
Refinement                        G60A-cacodylate          wild-type PTE-DEP 
_______________________________________________________________________
_ 
Protein nonhydrogen atoms        10,161                          5,116 
Water molecules                 1,026                            863 
Rcryst3              0.164                            0.141 
Rfree3              0.226                            0.192 
Average B-factor, (Å2)  
   Main chain       19.9                              13.1 
   Side chains       22.4                              15.0 
   Waters       28.2                              14.0 
RMSD from ideal geometry 
   Bond length, Å                 0.015                           0.014 
   Bond angles, (°)                 1.4                               1.4 
 
 
_____ 
1Values in parentheses correspond to highest resolution shell 2.02 to 1.95 Å for G60A, 
1.90 to 1.83 Å for wild-type PTE with DEP.  
2Rmerge = j|Ij(hkl) – <I(hkl)>|/j|<I(hkl)>|, where Ij is the intensity  
measurement for reflection j and <I> is the mean intensity over j reflections. 
3Rcryst/(Rfree) = ||Fobs(hkl)| – |Fcalc(hkl)||/|Fobs(hkl)|, where Fobs and  
Fcalc are observed and calculated structure factors, respectively.  No  
-cutoff was applied.  5% of the reflections were excluded from the refinement  
and used to calculate Rfree. 
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calculations on the optimized structures using the CPCM method (77-80). The dielectric 
constant (ε) was chosen to be 4. Frequency calculations were performed at the same 
theory level as the optimizations to obtain zero-point energies (ZPE) and to confirm the 
nature of the stationary points. All calculations were performed using the Gaussian03 
(81).  This computational study was performed by Dr. Shi-Lu Chen and Dr. Fahmi Himo 
from Royal Institute of Technology at Sweden.  
 
Results 
           Inhibition by Cacodylate.  The kinetic constants of kcat, kcat/Km, and Km for the 
hydrolysis of paraoxon by Co/Co-G60A are 2900 s-1, 1.34 x 107 M-1 s-1, and 210 μM, 
respectively.  The inhibition of Co/Co-G60A was measured using cacodylate as an 
inhibitor of paraoxon hydrolysis.  The double reciprocal plots (data not shown) intersect 
to the left of the vertical axis and thus cacodylate is a noncompetitive inhibitor versus 
paraoxon.  The kinetic inhibition constants, Kis and Kii, determined from fits of the data 
to equation 2, are 260 ± 100 mM and 110 ± 10 mM, respectively.   
Structure of G60A with Cacodylate.   The crystals of G60A contain two 
homodimers in the asymmetric unit.  As expected, two metal atoms were found in the 
active site for each monomer; however, an additional strong feature in the electron 
density was observed close to the binuclear metal center in all subunits during the 
refinement.  The tetrahedral electron density appeared to interact directly with both zinc 
atoms and was consistent with cacodylate.  The average B-factors for main chain protein 
atoms and cacodylate are 20.52 and 20.70 Å2, respectively. Cacodylate is bound to both  
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Figure 2.2  Model for the active site of Co/Co-PTE hybrid (mutant G60A) obtained 
from crystals grown in the presence of cacodylate. 
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metal ions with an average distance of 1.98 ± 0.03 and 2.07 ± 0.06 Å to the α- and β-
metal, respectively.  The α-metal ion is coordinated to His-55, His-57, and Asp-301 
whereas the β-metal ion is coordinated to His-201 and His-230.  An image of these 
interactions is presented in Figure 2.2.  The cacodylate ligand has replaced the bridging 
hydroxide that has been observed in a number of PTE structures (24).   No water 
molecules are observed to interact with either metal ion in any of the four molecules in 
the asymmetric unit of the G60A structure.  In addition to zinc, cacodylate is within 
hydrogen bonding distance of Trp-131, the carboxylated Lys-169, His-201, and Asp-
301.    
Structure of Wild-Ttype PTE with Diethyl Phosphate.  Diethyl phosphate (DEP) 
is the hydrolysis product of paraoxon, the best known substrate for PTE.  Various 
concentrations of DEP, as high as 100 mM, were tested for co-crystallization with wild-
type PTE before an optimized condition was determined.  In the co-crystals, electron  
density for DEP was unambiguously located around the binuclear metal site in one 
subunit.  However, the lack of electron density corresponding to one of the two ethyl 
groups within the ligand was observed in the second subunit.  The electron density was 
modeled as mono ethyl phosphate during the refinement for this subunit.  The 
phosphoryl oxygen atom, which is not coordinated to either metal, is relatively solvent 
exposed and the ethyl group occupies a more buried hydrophobic pocket.  Subsequent  
NMR experiments showed that the initial concentration of mono ethyl phosphate in the 
sample of diethyl phosphate was negligible (<1%), and the enzymatic hydrolysis of DEP 
by PTE was beyond the detection limit even after incubation of PTE with DEP for 5  
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Figure 2.3  Model for the active site of wild-type Co/Co-PTE from crystals grown in the 
presence of diethylphosphate.   
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days (data not shown).  These observations suggest that the ethyl group of the second 
DEP is not observed due to disorder.   
With the exception of the missing ethyl group, both ligands of DEP bind in a 
very similar manner within the binuclear metal center.  Therefore, the following 
discussion will refer only to the first subunit that contains the fully modeled DEP.  One  
of ethyl groups orients toward a hydrophobic patch, composed of Gly-60, Ile-106, Trp-
131, and Leu-303.  The other ethyl group is more solvent exposed and forms hydrogen 
bonds through the phosphate ester oxygen with two water molecules.  One of the 
phosphoryl oxygen atoms of DEP is 1.97 Å away from α-metal ion while the other 
oxygen is 2.17 Å away the β-metal.  The orientation of diethyl phosphate within the 
active site of PTE is presented in Figure 2.3.  These distances are similar to the 
orientation of cacodylate in the G60A PTE structure.  Moreover, there is no bridging 
water observed in the binuclear metal site, as a result of the complete displacement by 
DEP.  The DEP ligand is within hydrogen bonding distance from Nε1 of Trp-131, 
carboxy oxygen atoms of the carboxylated Lys-169, and carboxy oxygen atoms of Asp-
301.  Nδ1 of His-201 is slightly further away from DEP (3.39 Å) in the structure of the 
wild-type enzyme than from cacodylate (3.19 Å) in the G60A structure. 
DFT Calculations.  To examine the feasibility of the base mechanism proposed 
by Ollis and co-workers (42), we have performed DFT calculations using the same 
model of the Zn/Zn-enzyme active site as in the previous calculations (66).  The model 
is based on the high resolution crystal structure of wild-type Zn/Zn-PTE from P. 
diminuta (PDB code: 1HZY) and consists of the two zinc ions and their first shell  
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Figure 2.4  Optimized geometries of the Zn/Zn−PTE active site model with dimethyl 4-
nitrophenyl phosphate and a water molecule bound (React), the transition state for the 
water attack on the phosphorus (TS), and the resulting pentacoordinate intermediate 
(Inter). Distances are in angstroms. 
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ligands, including the bridging hydroxide, the four histidines (His-55, His-57, His-201, 
His-230), the Asp-301, and the carboxylated Lys-169.  Hydrogen atoms were added 
manually and the ligands were truncated so that in principle only side chains were kept 
in the model. The histidines were thus represented by imidazoles, the aspartate by an 
acetate, and the carboxylated lysine by a carboxylated methylamine (see Figure 2.4).  
Dimethyl-4- nitrophenyl phosphate was chosen as a model substrate, as in the previous 
study (66).  The water molecule, postulated to be the nucleophile in the base mechanism, 
was added to the model. The model consists thus of 85 atoms and has a total charge of 
+1. 
 In the reactant species (Figure 2.4, React), the phosphoryl oxygen of the 
substrate binds to the more solvent-exposed β-Zn site and the leaving group is located at 
the position opposite to the bridging hydroxide.  According to the base proposal, the 
nucleophilic water molecule is bound to the α-Zn.  In the calculations, we first placed the 
water molecule there, but we could not locate a stable conformation with the water  
bound to the α-Zn.  Instead, it dissociates from the Zn during the optimization and forms 
a hydrogen bond to the bridging hydroxide (see Figure 2.4, React).  From these 
calculations it can thus be concluded that a hexacoordinate α-Zn is quite unlikely.       
            We have furthermore optimized the transition state for the nucleophilic attack 
with the bridging hydroxide acting as a base.  The optimized structure is displayed in 
Figure 2.4 with important distances indicated.  The critical distance between the water 
oxygen to the phosphorus center (OW-P) is 1.99 Å.  Simultaneously with the OW-P bond 
formation, one proton of water molecule is transferred to the bridging oxygen, indicating 
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that the bridging hydroxide serves as the general base to activate the attacking water.  
This attack results in the penta-coordinate intermediate shown in Figure 2.4.  The barrier 
and reaction energy for this step are calculated to be +17.3 and +13.3 kcal/mol, 
respectively.  The barrier for the base mechanism is thus significantly higher than the 
previously calculated barrier where the bridging hydroxide is the nucleophile (11.7 
kcal/mol, 10).  These findings provide thus additional evidence that the bridging 
hydroxide acts as a nucleophile and not as a general base in the Zn/Zn-PTE reaction.  
 
Discussion 
Enzyme-Product Complexes with PTE.  The X-ray crystal structures of the 
diethyl phosphate product complex and an inhibitor complex with cacodylate has been 
determined with the phosphotriesterase from P. diminuta.  The structures of these two 
complexes were elucidated in an attempt to provide experimental support for recent 
variations in the reaction mechanism that have been postulated for this enzyme (41, 42).  
With the diethyl phosphate product, the ligand is found bridging the two divalent cations 
as illustrated in Figure 2.3.  The two metal ions are separated by a distance of 4.0 Å, 
where one of the negatively charged phosphate oxygens of the product is 2.1 Å from the 
α-metal ion while the other oxygen is 1.9 Å from the β-metal ion.  There are no water 
molecules associated with either metal within a distance of 5.4 Å.  The distances are 
summarized in Figure 2.5.  The symmetrical bridging observed in this complex differs 
from the prediction of this structure based upon the calculations of Wong and Gao (41).   
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Figure 2.5  Schematic representations of the binuclear metal centers of the binuclear 
metal centers from the Co/Co−PTE hybrid in the presence and absence of diethyl 
phosphate and cacodylate. (A) Zn/Zn−PTE hybrid in the absence of added ligands (PDB 
entry 1HZY). (B) Co/Co−PTE hybrid in the presence of added diethyl phosphate (PDB 
entry 3CAK). (C) Co/Co−G60A PTE hybrid in the presence of cacodylate (PDB entry 
2O4Q).  
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They have postulated that the diethyl phosphate product would be bound asymmetrically 
to the binuclear metal center with exclusive coordination to the β-metal ion and a metal-
metal separation of 5.3 Å.  It is unclear from the structure determined here whether or 
not the carboxylate side chain of Asp-301 is protonated or not.  However, the distance of 
the nearest carboxylate oxygen of Asp-301 is found 2.4 Å from the α-metal ion in the 
diethyl phosphate complex compared with a distance of 2.5 Å in the unliganded complex  
(39).  In any event, the structure of diethyl phosphate bound to PTE determined here is 
consistent with the complex proposed by Aubert et al. (39).  There is no indication that 
the two divalent cations can be separated by a distance that approaches that of 5.3 Å 
predicted by Wong and Gao.  The experimentally determined complex resembles that of 
a highly symmetric bridge with nearly equal distances between each metal ion and the 
nearest phosphate oxygen. 
            A nearly identical structure is observed in the complex with the cacodylate anion 
(Figure 2.3).  The G60A mutant has kinetic constants nearly identical to those of the 
wild-type enzyme for the hydrolysis of paraoxon but is more stereoselective for the 
hydrolysis of substrates with larger substituents attached to the phosphorus core (44, 82-
84). Cacodylate is an analogue of the diethyl phosphate product since it bears a single 
negative charge within a tetrahedral architecture.  The coordination geometry of this 
ligand to the binuclear metal center is nearly symmetric with oxygen-metal distances of 
2.0 and 2.1 Å to the α- and β-metal ions respectively.  There are no water molecules 
coordinated to either metal within a distance of 3.0 Å.   
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The coordination geometry of the diethyl phosphate and cacodylate bound to the 
binuclear metal center of PTE is not consistent with the mechanism for phosphotriester 
hydrolysis proposed by Jackson et al (42).  For the phosphotriesterase isolated from A. 
radiobacter it has been postulated that the bridging hydroxide acts not as a nucleophile 
but as a general base in the abstraction of a proton from a water molecule coordinated to 
the α-metal ion.  The primary experimental support for this conjecture stems from the 
determination of the structures of diethyl thiophosphate and dimethyl thiophosphate 
bound to the active site of the PTE from A. radiobacter (42, 67).  These structures reveal 
a bridging complex for either thiophosphate product plus the coordination of an 
additional bridging hydroxide.  These complexes are consistent with the mechanism 
illustrated depicted in Scheme 2.3.  However, to the best of our knowledge, there have 
been no crystal structures of PTE, or any other member of the amidohydrolase 
superfamily, where the α-metal ion is 6-coordinate with an additional water molecule 
that could function as the primary nucleophile.  Thus, experimental support for an 
additional water molecule that is activated by the bridging hydroxide is lacking.  The 
identities of the metal ions bound to the PTE from A. radiobacter are also different from 
the PTE from P. diminuta.  The structure of this enzyme was determined with Fe in the 
α-position and Zn in the β-position.  Hexacoordinate zinc complexes are extremely rare 
and thus it seems quite unlikely that the PTE from P. diminuta could function in the 
manner as proposed by Ollis and coworkers. The DFT calculations presented here give 
further support to this conclusion. It was not possible to optimize a structure in which an 
additional water molecule is bound to the R-Zn atom and the barrier for the base 
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mechanism is calculated to be significantly higher than that for the nucleophile 
mechanism. 
Product Complexes in the Amidohydrolase Superfamily.  X-ray crystal structures 
have been determined for other members of the amidohydrolase superfamily (23).  It 
seems reasonable to assume that for those enzymes in this superfamily that contain a 
binuclear metal center that many aspects of the chemical reaction mechanisms would be 
quite similar to one another.  Structures of these enzymes, determined in the presence of 
their respective hydrolysis products, should illuminate whether or not the diethyl 
phosphate structure, determined for PTE, provides a common mechanistic or structural 
theme for the rest of the amidohydrolase superfamily. 
Isoaspartyl dipeptidase (IAD) catalyzes the hydrolysis of amide bonds formed with the 
side chain carboxylate of aspartic acid (85).   A 2.1 Å resolution structure of this enzyme 
has been determined in the presence of aspartate, the reaction product (86) .  A 
representation of the structure is illustrated in Figure 2.6 showing the bound aspartate.  
The carboxylate side chain is found bridging the two zinc atoms within the active site in 
a somewhat asymmetric arrangement.  The two metal ions are separated by a distance of 
3.8 Å.  The carboxylate oxygen nearest the α-metal is separated by a distance of 2.8 Å 
while the other oxygen is 2.3 Å away from the β-metal ion.  There are no other water 
molecules within 4.1Å of either metal ion.  A similar complex is also observed in the 
structure of acetate bound within the active site of D-aminoacylase (Figure 2.6).  This 
enzyme catalyzes the hydrolysis of the amide bond of N-acetyl-Damino acid derivatives 
(87, 88). This particular enzyme requires a divalent cation bound to the β-site but is less  
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Figure 2.6  Schematic representations of the binuclear metal centers for isoaspartyl 
dipeptidase, d-aminoacylase, and dihydroorotase in the presence of bound reaction 
products. (A) Isoaspartyl dipeptidase in the presence of aspartic acid (PDB entry 
1ONX). (B) d-Aminoacylase in the presence of acetate (PDB entry 1M7J). (C) 
Dihydroorotase in the presence of carbamoyl aspartate (PDB entry 1J79). 
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particular about the requirement for the occupancy of α metal ion at the α-site.  In any 
event, the coordination of acetate to the active site shows that the two metal ions are 3.2 
Å from one another.  One of the oxygens of the bound acetate is 2.5 Å from the α-metal 
whereas the other oxygen is 2.0 Å from the β-metal.  There are no other water molecules 
that are bound to either metal ion.   
Dihydroorotase catalyzes the reversible interconversion of carbamoyl aspartate 
and dihydroorotate in the biosynthetic pathway for the assembly of pyrimidine 
nucleotidess.  When the structure of this enzyme was determined in the presence of 
added dihydroorotate it was found, quite remarkably, that in one subunit of the dimer 
dihydroorotate was bound, while in the adjacent subunit carbamoyl aspartate was bound.  
Thus the structure of this enzyme-substrate/product complex provided a nearly 
unprecedented view of the reaction immediately before and after the chemical reaction 
had been catalyzed.  In the complex with the bound carbamoyl aspartate the two zinc 
atoms are separated by a distance of 3.7 Å.  One of the carboxylate oxygens is 2.3 Å 
away from the α-metal ion while the other oxygen is 2.2 Å away from the β-metal ion 
(89).  Thus, the bridging complex is symmetric and there are no other visible water 
molecules that could function as the nucleophile in the complex with dihydroorotate.   
 
Conclusion 
The structure of PTE from P. diminuta has been determined in the presence of 
the hydrolysis product diethyl phosphate and a product analogue, cacodylate.  In either 
structure the complex is formed as a bridging ligand between the two divalent cations is 
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a symmetric orientation where the average oxygen-metal distance is 2.0 Å.  The average 
metal-metal separation in this complex is 3.9 Å, compared with 3.4 Å in the unliganded 
complex.  In either structure there is no evidence for the additional binding of hydroxide 
to either of the two divalent cations.  These results provide strong experimental support 
for the coordination geometry of the reaction product, originally postulated by Aubert et 
al. and illustrated in Scheme 2.2.  The enzyme-product complex, predicted by Wong and 
Gao to be asymmetrically associated with only the β-metal ion coupled with a metal-
metal separation of 5.3 Å, is not supported by these results (41).  The structures 
presented in this paper are also at variance with the proposed mechanism postulated by 
Ollis and coworkers (42, 67).  In the complex with diethyl phosphate there is no 
evidence for the binding of an additional hydroxide as a bridging ligand between the two 
divalent cations.  These results support the computational assessment of the reaction 
mechanism of PTE which have concluded that the bridging hydroxide is sufficiently 
nucleophilic to attack the phosphorus center of organophosphate triester substrates (66, 
90).  The formation of product complexes with the simultaneous complexation of 
hydroxide and product in the active site of PTE from A. radiobacter are likely the result 
of iron occupying the α-metal ion site of that enzyme.    
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CHAPTER III 
STEREOSELECTIVE DETOXIFICATION OF ORGANOPHOSPHATE NERVE 
AGENT ANALOGUES BY BACTERIAL PHOSPHOTRIESTERASE 
 
Introduction 
Organophosphorus compounds have been utilized for more than 50 years as 
insecticides for the protection of agricultural crops (91).  Similar compounds have been 
developed as chemical warfare agents (48).  The structures for some of these compounds 
are presented in Scheme 3.1 including tabun (GA), sarin (GB), soman (GD), cyclosarin 
(GF), VX and rVX.  GA contains a cyanide leaving group, while the three other G-
agents (GB, GD, and GF) have a fluorine leaving group and the two versions of VX 
contain a thiolate leaving group.  The primary toxicity of organophosphorus compounds 
is due to the inhibition of acetylcholinesterase (AChE). AChE is an enzyme that 
catalyzes the hydrolysis of acetylcholine at neural synapses through the phosphorylation 
of an active site serine residue (92).  GA, GB, GF, VX, and rVX contain a chiral 
phosphorus center and thus each of these nerve agents has two stereoisomers, while 
soman has four stereoisomers due to an additional chiral center within the pinacolyl 
substituent.  The enantiomers are different in toxicity.   The Sp-stereoisomer of sarin 
reacts with AChE approximately ~104 times faster than the Rp- stereoisomer and the Sp- 
stereoisomers of soman react ~105 times faster than the Rp-isomers.  Similarly, the Sp-
stereoisomer of VX is 100-fold more toxic than is the Rp- stereoisomer (48).  
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Scheme 3.1  The chemical structures of the organophosphate nerve agents, tabun (GA), 
sarin (GB), soman (GD), cyclosarin (GF), VX and rVX. 
 
The detoxification of the organophosphorus nerve agents has been accomplished 
through the utilization of organophosphate degrading enzymes such as the human 
paraoxonase 1 (PON1), squid DFPase, organophosphorus acid anhydrolase (OPAA), and 
phosphotriesterase (PTE).  Human paraoxonase is capable of hydrolyzing GB, GD, and 
VX but the overall catalytic activity is relatively low (52).  DFPase, isolated from Loligo 
vulgaris, is able to hydrolyze GA, GB, GD, GF, and DFP.  The values of kcat and kcat/Km 
for the hydrolysis of DFP are 526 s-1 and 1.3 x 106 M-1 s-1, respectively, but the catalytic 
activities towards the hydrolysis of GB and GD are significantly lower (50, 51).  
Organophosphorus acid anhydrolase (OPAA) from Alteromonas sp. JD6.5 is a member 
of a family of enzyme that is capable of hydrolyzing a wide variety of organophosphorus 
compounds, including GB, GD and GF but not VX (53).  Phosphotriesterase was first 
isolated from soil microbes (93).  The best substrate for PTE is the agricultural pesticide 
paraoxon and the value for kcat/Km approaches the diffusion controlled limit of ~ 108 M-1 
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s-1 (64).  The enzymatic reaction for the hydrolysis of paraoxon to p-nitrophenol and 
diethyl phosphate is shown in Scheme 3.2.  The substrate specificity of PTE is quite 
broad and it is capable of hydrolyzing GA, GB, GD, GF, and VX (58).  PTE is reported 
to be one of the few enzymes capable of hydrolyzing the P-S bond in the nerve agents 
VX and rVX (94).  
Scheme 3.2  The chemical reaction for the hydrolysis of paraoxon catalyzed by the PTE. 
 
 
 
PTE is a homodimeric protein that contains a binuclear metal center embedded 
within an (/)8 barrel structure and is a member of the amidohydrolase superfamily 
(24).  The native enzyme contains two Zn 2+ ions that can be substituted with Cd2+, Co2+, 
Ni2+, and Mn2+ without loss of catalytic activity (64).   The two metals are bridged by a 
carboxylated lysine (Lys-169) and a hydroxide ion. The more solvent-shielded metal 
(Mα) is coordinated to His-55, His-57, and Asp-301.  The more solvent-exposed metal 
(Mβ) is coordinated to His-201 and His-230.  Previous investigations have identified 
three binding subsites within the active site of PTE.  These include a small, a large and a 
leaving-group pocket (37).  The small pocket is defined by the side chains of Gly-60, Ile-
106, Leu-303, and Ser-308.  The large pocket is formed by His-254, His-257, Leu-271, 
and Met-317.  The leaving group pocket is surrounded by four residues: Trp-131, Phe-
132, Phe-306, and Tyr-309.  The substrate binding site of PTE is graphically shown in 
Figure 3.1.  
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Figure 3.1  Graphic representation of the binding pockets within the active site of PTE. 
The small pocket consists mainly of Gly-60, Ile-106, Leu-303, and Ser-308.  The large 
pocket primarily contains His-254, His-257, Leu-271, and Met-317.  The leaving group 
pocket is surrounded by Trp-131, Phe-132, Phe-306, and Tyr-309 (37). 
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The wild-type PTE is stereoselective for the hydrolysis of chiral  
organophosphates (44, 95, 96).  The degree of stereoselectivity depends on the specific 
substituents attached to the central phosphorus core.  For example, the wild-type PTE 
hydrolyzes the Sp-enantiomer of methyl phenyl 4-acetylphenylphosphate approximately 
two orders of magnitude faster than the Rp-enantiomer (96).  In addition, the active site 
has been shown to be susceptible for manipulation of the stereoselectivity through the 
mutation of residues that contact the substrates prior to catalytic turnover.  The G60A 
mutant hydrolyzes the Sp-enantiomer of methyl phenyl 4-acetylphenylphosphate about 5 
orders of magnitude faster than the Rp-enantiomer and thus the stereoselectivity can be 
significantly enhanced (96).  Unfortunately, the inherent stereoselectivity of the wild- 
type PTE does not match that of AChE.  It preferentially hydrolyzes the less toxic 
enantiomer of chiral organophosphates (45).  However, it has been demonstrated that the 
stereoselectivity of the wild-type PTE can be inverted through multiple mutations to the 
small and large pockets in the active site.  For example, the I106G/F132G/H257Y 
mutant catalyzes the hydrolysis of the Rp-enantiomer of methyl phenyl 4-
acetylphenylphosphate about 3 orders of magnitude faster than the Sp-enantiomer (96).  
This represents a change in stereoselectivity of 8 orders of magnitude relative to the 
G60A mutant with only four amino acid changes.      
   In this chapter, we describe the synthesis of chiral analogues of GB, GD, GF, 
VX, and rVX with a 4-acetylphenol leaving group (Scheme 3.3).  We have utilized these 
compounds to identify mutants of PTE that are enhanced in their ability to hydrolyze the 
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more toxic Sp- enantiomers.  In the following chapter we describe the crystal structures 
and molecular dynamics calculations of a subset of the more optimized mutants in an 
attempt to correlate the changes in active site structure with changes in the catalytic 
properties of the various mutant enzymes.  
Scheme 3.3  The chemical structures of organophosphonate nerve agent analogues. 
 
 
 
 
 
 
 
 
Materials and Methods 
           Materials.  Racemic mixtures and the isolated Sp- and Rp- enantiomers of the 
organophosphonate compounds shown in Scheme 3.3 were synthesized by Dr. 
Yingchun Li. Escherichia coli (DE3) and XL1-blue cells were purchased from 
Stratagene.  The expression plasmid pET20b (+) was obtained from Invitrogen.  The 
bacterial phosphotriesterase and the site-directed mutants (G60A, I106G, F132G, 
S308G, I106G/H257Y, I106G/F132G/H257Y, I106A/F132A/H257Y, 
I106A/H257Y/S308A, and H254G/H257W/L303T) were purified to homogeneity as 
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previously described (44, 95, 97).  The H254Q/H257F mutant was discovered by 
creating a H254X/H257X library based on the wild-type PTE sequence as the template 
(59). The H257Y/L303T mutant was found using a H254X/H257X library based with 
the L303T mutant as the parental template (98).  The H254Q/H257F mutant was isolated 
as a more active variant by screening the VX analogue, dementon-S.  The H257Y/L303T 
mutant was isolated as an improved variant from screening the Sp- enantiomers of GB 
and GD analogues.  
Expression, Growth, and Preparation of Wild-Type and Mutant Enzymes.  The 
gene for the expression of PTE (opd) was cloned between the NdeI and EcoRI sites of a 
pET20b (+) plasmid.  The plasmids for the expression of the wild-type and mutant 
enzymes were transformed into the E. coli strain BL-21 cells (DE3) (64).  The 
transformed BL-21cells were inoculated in Luria-Bertani (LB) broth overnight at 37 °C.   
The overnight cultures were then incubated in Terrific Broth (TB) containing 100 μg/mL 
ampicillin and 1.0 mM CoCl2 at 30 °C.  The expression of PTE was induced by the 
addition of 1.0 mM IPTG when the OD600 reached 0.4.  The cells were harvested at 4 °C 
by centrifugation at 6,000 rpm after allowing the culture to reach stationary phase after 
36-42 hours at 30 °C.  All subsequent steps were carried out at 4 °C (or on ice).  When 
the wild-type and mutants of PTE were purified, the cells were suspended with 10 mM 
HEPES buffer, pH 8.5, and lysed with a 5-s pulsed sonication for 24 min at 0 °C at 
medium power setting using a Heat System-Ultrasonics, Inc. (Farmington, NY) model 
W830 ultrasonic processor.  The lysed cell suspensions were combined and centrifuged 
at 13,000 rpm for 15 min.  The supernatant was decanted, and then a solution of 
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protamine sulfate (2% w/v) was added dropwise over a 20-min period while stirring until 
the protamine sulfate concentration reached 0.4%.  The mixture was allowed to stir for 
an additional 20 min before centrifugation at 13,000 rpm.  The supernatant solution was 
then subjected to ammonium sulfate fractionation by the addition of solid ammonium 
sulfate to 60% saturation (371 mg/mL of protein solution) while stirring for 45 min.  The 
pellet was collected by centrifugation at 13,000 rpm for 30 min and the protein was 
recovered by resuspending the pellet in buffer. The protein was loaded onto a gel 
filtration column containing Ultrogel AcA 54 (IBF, Columbia, MD) and eluted at a flow 
rate of 1.0 mL/min.  The fractions were pooled based on enzymatic activity and 
absorbance at 280 nm.  The pooled fractions were then loaded to a column containing 
DEAE-Sephadex A-25 previously equilibrated with 10 mM HEPES buffer, pH 8.5.  
SDS-polyacrylamide gel electrophoresis demonstrated that all of the mutant enzymes 
were the same size as the wild-type PTE and that the purity of all proteins was greater 
than 95%.  
Spectrophotometric Enzyme Assays.  The kinetic constants for each substrate 
were determined by monitoring the formation of para-acetylphenol at 294 nm (ε = 7710 
M-1cm-1) at 30 °C using a SpectraMax plate reader (Molecular Devices Inc., Sunnyvale 
CA).  The assay mixtures contained 50 mM CHES buffer pH 9.0, 100 μM CoCl2, and 
various concentrations of substrates.  The reactions were initiated by the addition of 
enzyme.  Due to the limited solubility of compounds 4 and 5, 10% methanol (v/v) was 
added to the assay mixtures for these compounds. 
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 Data Analysis.  The kinetic constants (kcat and kcat/Km) were obtained from a fit 
of the data to equation 1, where v is the initial velocity, kcat is the turnover number, [A] is 
the substrate concentration, Et is the enzyme concentration, and Km is the Michaelis 
constant.  
                                        v / Et = kcat [A] / (Km + [A])                                                  (3.1) 
 
Results 
Selection of Mutants.  The residues in the binding pocket were selected as targets 
for the mutations.  The smallest residue in the small pocket of PTE, Gly-60, was mutated 
to alanine in order to explore the effect of the size reduction of the small pocket.  To 
investigate the enlargement of the small pocket or the leaving group pocket, the residues, 
Ile-106 and Ser-308, in the small pocket, and Phe-132 in the leaving group pocket, were 
mutated to glycine as single site mutants of PTE.  Other mutants contain alternations of 
both the small and the large pockets.  The size of the small pocket was enlarged and the 
size of the large pocket was decreased, or the configuration of the large pocket was 
adjusted.  All of the mutants were expressed in E. coli and purified for measurement of 
catalytic activity.  The kinetic parameters of the wild-type and the mutants of PTE 
towards the compounds that appear in Scheme 3.3 are shown in Tables 3.1 and 3.2.  The 
stereoselectivity of the wild-type and each mutant towards the chiral enantiomers are 
shown in Table 3.3.  
           The Catalytic Activity and the Stereoselectivity of the Wild-Type PTE.  The kcat 
and kcat/Km values for the wild-type PTE towards compounds 2, 3, 4 and 5 illustrate the  
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Table 3.1  Maximum velocity (s-1) for the wild-type and mutants of PTE. 
 
 
WT G60A I106G F132G S308G H254Q/ 
H257F 
H257Y/
L303T 
I106G/
H257Y  
I106G/
F132G/
H257Y 
I106A/
F132A/
H257Y  
I106A/
H257Y/
S308A 
H254G/ 
H257W/ 
L303T 
 Rp/Sp-1 3.9e2 1.6e2 1.8e2 1.8e2 NDa 3.8e1 1.7e2 4.8e2 1.5e2 7.9e2 2.3e3 2.7e2 
Rp-1 1.5e2 1.3e2 6.8e1 6.8e1 1.1e2 1.7e2 7.3e0 8.9e1 3.4e1 ND 2.0e2 1.4e1 
Sp-1 6.7e2 1.1e2 3.0e2 3.0e2 2.9e2 3.2e1 4.1e2 6.8e2 3.5e2 9.0e2 1.4e3 1.9e2 
Rp/Sp-2 9.7e1 1.1e2 3.9e1 2.9e1 1.8e2 1.2e1 3.2e2 5.9e1 5.3e1 1.6e2 6.5e2 1.2e2 
Rp-2 1.0e2 1.2e2 4.0e1 3.9e1 2.5e2 4.8e1 1.8e1 4.7e1 ND 4.5e1 1.3e2 ND 
Sp-2 4.0e1 7.4e0 2.8e1 1.6e1 1.5e1 7.2e0 3.7e2 1.0e2 4.8e1 5.1e2 3.4e2 9.2e1 
Rp/Sp-3 5.4e1 4.7e1 4.9e1 3.5e1 1.2e2 1.1e1 1.3e2 4.7e2 ND 6.3e2 6.7e2 4.7e1 
Rp-3 9.3e1 3.7e1 3.1e1 2.8e1 1.1e2 7.0e1 5.1e1 8.4e0 ND ND 2.2e1 2.0e1 
Sp-3 2.2e1 ND 4.8e1 2.5e1 1.2e1 6.3e0 1.0e2 2.1e2 2.3e2 2.3e2 5.3e2 5.0e1 
RpRc/RpSc 
/SpRc/SpSc-4 
2.1e0 4.1e0 1.2e0 ND 1.1e0 1.3e0 2.4e0 2.4e-1 2.9e-2 4.3e-1 1.1e0 1.8e1 
RpRc/SpRc-4 2.5e0 3.9e0 ND ND 2.5 e0 8.2e-1 3.0e0 4.8e-1 4.2e-2 5.0e-1 7.8e-1 1.1e1 
RpSc/SpSc-4 6.1e-1 1.3e0 9.0e-2 1.3e-1 4.2e-1 4.2e-1 8.0e-1 1.6e-2 4.1e-2 1.1e-1 1.4e-1 4.6e0 
RpRc-4 3.4e0 8.5e0 3.3e0 1.2e1 2.2 e0 5.5e-1 4.1e-1 7.6e-2 4.9e-2 5.0e-2 1.7e-1 2.0e0 
RpSc-4 4.5e-1 1.5e0 1.5e-1 1.5e-1 6.2e-1 1.7e-1 ND 6.5e-2 5.5e-3 ND 4.2e-2 2.1e-1 
SpRc-4 7.7e-1 9.5e2 5.0e-2 3.2e-1 5.0e-1 6.3e-1 6.3e0 3.7e-2 1.6e-1 7.4e-1 1.0e0 1.2e1 
SpSc-4 1.6e-2 ND ND 1.2e-1 1.2e-1 3.3e-1 2.1e0 2.2e-2 5.3e-2 2.4e-1 3.5e-1 2.9e0 
Rp/Sp-5 2.8e1 1.9e1 1.1e1 5.4e0 8.4e1 3.8e1 4.5e0 7.8e0 1.6e1 2.4e0 ND 1.3e1 
Rp-5 ND 9.3e1 ND 1.4e1 1.5e2 3.8e1 5.9e0 ND ND ND 4.2e0 8.1e-1 
Sp-5 ND ND 5.1e0 3.3e-1 1.4e-1 ND 5.1e0 1.8e1 1.3e1 4.7e0 4.5e0 1.9e1 
 
a ND represents the enzymes were not saturated under 3mM of the substrates.  
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Table 3.2  kcat/Km (M-1s-1) for the wild-type and mutants of PTE.  
 
 
 
WT G60A I106G F132G S308G H254Q/ 
H257F 
H257Y/
L303T 
I106G/
H257Y  
I106G/
F132G/
H257Y 
I106A/
F132A/
H257Y  
I106A/
H257Y/
S308A 
H254G/ 
H257W/ 
L303T 
Rp/Sp-1 7.2e5 2.7e5 9.4e4 2.2e5 9.8e4 1.9e6 7.6e4 1.8e5 8.3e4 1.6e5 2.6e5 7.8e4 
Rp-1 4.9e5 5.2e5 6.2e4 3.5e4 7.5e4 1.5e6 2.4e3 3.3e4 6.3e3 6.9e3 6.0e4 1.5e3 
Sp-1 1.2e6 1.3e5 7.7e4 3.3e5 1.5e5 7.1e6 1.6e5 3.8e5 1.1e5 3.5e5 7.2e5 2.2e5 
Rp/Sp-2 2.4e5 2.5e5 3.3e4 2.7e4 5.4e4 8.4e5 3.9e4 1.2e4 4.9e3 3.0e4 3.1e4 4.0e4 
Rp-2 5.8e5 5.2e5 5.8e4 5.9e4 1.1e5 8.2e5 2.5e3 8.9e3 1.5e3 2.3e3 1.9e4 1.8e3 
Sp-2 2.7e4 6.2e3 3.3e3 5.5e3 3.1e3 1.2e6 1.1e5 3.0e4 6.8e3 5.0e4 6.7e4 5.9e4 
Rp/Sp-3 2.7e5 5.2e5 5.4e4 8.3e4 1.1e5 5.2e5 5.3e4 6.0e4 3.6e4 5.9e4 1.7e5 9.9e4 
Rp-3 8.5e5 7.6e5 6.2e4 1.2e5 1.8e5 3.1e5 1.3e4 2.3e3 4.5e2 4.9e2 9.5e3 1.5e3 
Sp-3 3.4e4 9.9e1 4.4e4 3.6e4 9.5e3 1.6e6 7.3e4 1.5e5 9.1e4 1.3e5 3.9e5 1.8e5 
RpRc/RpSc 
/SpRc/SpSc-4 
3.8e2 8.2e2 7.1e1 1.6e2 5.0e2 2.8e2 7.3e2 2.6e1 7.6e0 6.2e1 1.2e2 1.9e3 
RpRc/SpRc-4 5.4e2 1.6e3 1.5e2 1.7e2 7.4e2 5.5e2 9.3e2 3.1e1 8.8e0 1.3e2 1.7e2 3.3e3 
RpSc/SpSc-4 1.2e2 2.6e2 2.8e1 2.3e1 2.1e2 6.3e1 3.1e2 3.9e0 2.8e0 1.7e1 2.3e1 7.7e2 
RpRc-4 1.3e3 3.0e3 3.8e2 3.3e2 2.3e3 1.9e2 5.8e1 1.7e1 8.4e0 2.3e1 5.9e1 2.2e2 
RpSc-4 2.0e2 5.9e2 5.0e1 4.5e1 4.9e2 5.5e1 1.6e1 2.3e0 1.1e0 1.2e0 4.5e0 1.3e2 
SpRc-4 1.1e2 1.7e1 1.4e1 8.4e1 1.1e2 1.6e3 1.8e3 8.0e0 1.3e1 1.5e2 2.4e2 8.1e3 
SpSc-4 3.2e0 1.1e0 1.0e1 5.2e0 6.7e0 6.2e1 2.5e2 2.1e0 4.5e0 2.2e1 3.0e1 1.7e3 
Rp/Sp-5 7.4e3 9.6e3 3.6e3 1.9e3 1.4e4 3.2e3 2.9e3 1.1e3 1.5e3 4.4e2 4.0e2 1.5e4 
Rp-5 1.6e4 2.1e4 4.9e3 2.9e3 2.8e4 5.2e3 1.9e3 3.8e2 5.2e1 7.5e1 8.4e2 2.5e2 
Sp-5 2.1e1 9.4e-1 8.4e2 8.1e1 1.0e2 3.3e2 5.8e3 2.6e3 4.6e3 1.0e3 5.7e2 2.8e4 
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Table 3.3  kcat/Km ratios [((kcat/Km)R/( kcat/Km)S ) for the hydrolysis of chiral substrates 
by the wild-type and mutants of PTE. 
 
 
 
 
 
 
 
 
 
 
 1 2 3 RpRc:RpSc:SpRc:SpSc -4 5 
Wild-type 1/2 22 25 398:63:35:1 755 
G60A 4 84 7650 3630:702:20:1 2300
0 
I106G 1 18 1 38:5:1.5:1 6 
F132G 1/9 11 3 64:8.5:16:1 35 
S308G 1/2 34 19 339:73:17:1 277 
H254Q/H257F 1/5 1/2 1/5 3:1:29:1 16 
H257Y/L303T 1/64 1/44 1/6 4:1:115:16 1/3 
I106G/H257Y 1/12 1/3 1/64 8:1:3:1 1/7 
I106G/F132G/H257Y 1/18 1/5 1/205 7:1:11:4 1/89 
I106A/F132A/H257Y 1/51 1/22 1/265 19:1:125:19 1/14 
I106A/H257Y/S308A 1/12 1/4 1/41 13:1:54:7 2 
H254G/ H257W/ L303T 1/142 1/33 1/121 2:1:65:14 1/111 
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preference of the wild-type enzyme for the Rp- enantiomers of the chiral 
organophosphonates, although a slight preference is shown for the Sp- enantiomer of 
compound 1.  The bigger the size of the substituent of the substrate, the greater the 
preference for the Rp- enantiomer.  For example, compound 2 has an O-isopropyl group 
as the substituent, the (kcat/Km)R/( kcat/Km)S ratio is 22, while the Rp- enantiomer of 
compound 4 contains an O-pinacolyl group as the substituent, the (kcat/Km)R/( kcat/Km)S 
ratio increases to 63.  The largest (kcat/Km)R/( kcat/Km)S ratio, 755, is seen with compound 
5 which contains an O-cyclohexyl group.  The wild-type enzyme displays the highest 
activity relative to other selected mutants to hydrolyze the Rp- enantiomers of 
compounds 2 and 3 with kcat/Km values of 5.8 x 105 M-1s-1 and 8.5 x 105 M-1s-1, 
respectively.  The catalytic ability of the wild-type enzyme towards the Sp- enantiomer 
of compound 1 is remarkable with a kcat/Km value of 1.2 x 106 M-1s-1.  However, the 
activity of the wild-type enzyme towards the Sp- enantiomers of compounds 2, 3, 4, and 
5 is lower.  The kcat/Km values are approximately 104 M-1s-1 for the Sp-enantiomers of 
compounds 2 and 3, and 101 M-1s-1 for the Sp- enantiomer of compound 5 and the SpRc- 
enantiomer of compound 4.  The catalytic efficiency for the SpSc- enantiomer of 
compound 4 is even lower with a kcat/Km value 3.2 M-1s-1.  The mutants containing the 
modification of the substrate binding pocket that reverses the stereoselectivity and 
enhances the hydrolytic activity were purified and studied for the detoxification of the 
more toxic Sp- stereoisomers of organophosphonates.   
            Enhancement of Stereoselectivity.  The small pocket residue, Gly 60, was 
mutated to alanine to decrease the size of the substrate binding pocket of PTE.  The kcat 
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and kcat/Km values of the G60A mutant were decreased for all of the Sp- enantiomers as 
shown in Scheme 3.3.  The catalytic efficiency of the G60A mutant towards the Sp-
enantiomers of the organophosphonate compounds was decreased up to 340-fold relative 
to the wild-type enzyme.  In contrast, the catalytic activity of the G60A mutant is 
increased towards the Rp- enantiomers of compounds 4 and 5 compared with the wild-
type enzyme.  The G60A mutant has the highest kcat/Km values for all of the PTE 
mutants towards the Rp- enantiomers of compound 4, 3.0 x 103 M-1s-1 and 5.9 x 102 M-1s-
1 for RpRc- 4 and RpSc- 4, respectively.  While the kcat/Km values of the wild-type are 1.3 
x 103 M-1s-1 and 2.0 x 102 M-1s-1 for RpRc- 4 and RpSc- 4, respectively.  For all of the 
compounds shown in Scheme 3.3, the larger the substituents, the greater degree of 
discrimination between the Rp- and the Sp- enantiomers for the wild-type and the G60A 
are greater.  The (kcat/Km)R/( kcat/Km)S ratios of the G60A mutant are increased relative to 
the wild-type.  The most drastic case is seen with compound 5 in which the Rp-
enantiomer is preferred by a factor of 23,000 compared to a factor of 755 for the wild-
type.  The catalytic preference of the G60A mutant for the hydrolysis of compounds 1-5 
is significantly enhanced due to the additional methyl group of the alanine which reduces 
the size of the small pocket of the active site.  Hence, the G60A is observed to have 
more pronounced stereoselectivity for the selected organophosphonates than the wild-
type PTE.   
Relaxation of Stereoselectivity.  A mutation to a smaller residue within the small 
pocket or the leaving group pocket of the substrate binding site of PTE will increase the 
size of the small or the leaving group pocket. The stereoselectivity for the compounds in 
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Scheme 3.3 are predicted to be relaxed.  For example, the I106G mutant increases the 
size of the small pocket and diminishes the stereoselectivity for compounds 1, 3, 4 and 5 
relative to the wild-type with (kcat/Km)R/( kcat/Km)S ratios less than 10.  The F132G 
mutant increases the size of the leaving group pocket and the stereoselectivity for 
compounds 2, 3, 4 and 5 compared to the wild-type enzyme are reduced.  The 
(kcat/Km)R/( kcat/Km)S ratios of the I106G mutant are less than 35.   
            The H257Y/L303T (YT) mutant increases the size of the small pocket and 
reduces the size of the large pocket.  The stereoselectivity of this mutant is inverted for 
each racemic mixture.  Interestingly, the H257Y/L303T (YT) exhibited more relaxed 
enantioselectivities for the compounds with larger substituents.  The (kcat/Km)R/(kcat/Km)S  
ratio is 1/3 for compound 5, which contains the substituent, O-cyclohexyl.  However, the 
enantioselectivity is less relaxed for the compounds with smaller substituents.  For 
example, the ratio is 1/64 for compound 1, which contains an O-ethyl substituent.  The 
I106A/H257Y/S308A mutant also increases the size of the small pocket and reduces the 
size of the large pocket.  This mutant displays a reversal in stereoselectivity for 
compounds 1, 2, 3, and 4.  However, the I106A/H257Y/S308A mutant shows the most 
relaxed stereoselectivity for the compound with the biggest substituent, compound 5.  
The ratio of (kcat/Km)R/( kcat/Km)S is only 2, whereas the ratio for the wild-type is 755.  
Modification of the large pocket was done by mutating His-254 and His-257 to 
glutamine and phenylalanine, respectively.  For the hydrolysis of compounds 1, 2 and 3 
by the H254Q/H257F (QF) mutant, the turnover number for the Rp- enantiomers is 
higher than for the Sp- enantiomers, but the Km value of the Sp- enantiomers of 
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compounds 1, 2, and 3 are more than 10-fold smaller than the Rp- enantiomers (less than 
10 μM).  Thus, the H254Q/H257F (QF) displays a relaxed stereoselectivity with 
(kcat/Km)R/( kcat/Km)S ratios of 1/5, 1, and 1/5 for compounds 2 and 3.  The kcat/Km values 
of the Sp- enantiomers of compound 1, 2, and 3 are remarkably high.  They are 7.2 x 10 6 
M-1s-1, 1.2 x 10 6 M-1s-1 and 1.6 x 10 6 M-1s-1, respectively.  
Reversal of Stereoselectivity.  The mutants that exhibit relaxed enatioselectivity 
towards the chiral substrates contain an expanded small pocket.  However, the inherent 
stereoselectivity can be inverted by enlarging the size of the small pocket and shrinking 
the size of the large pocket simultaneously.  The residues in the small pocket such as Ile-
106, Phe-132, and Ser-308 are replaced with smaller residues including glycine or 
alanine.  For the H257Y/L303T (YT) mutant, Leu-303 is changed to a relatively smaller 
residue, threonine.  In addition, these mutants include His-257 in the large pocket that 
has been mutated to a relatively larger residue, tyrosine.  Hence, reversed 
stereoselectivities are observed.  For example, the wild-type PTE prefers the Rp- 
enantiomer of compound 3 by a factor of 25, whereas the I106A/F132A/H257Y mutant 
inverts the stereoselectivity of this compound and prefers the Sp- enantiomer by a factor 
of 265.  One of the most interesting cases is observed with the H257Y/L303T mutant.  
This enzyme possesses a larger stereoselectivity for compound 1, which contains an 
ethyl group as the substituent.  The (kcat/Km)R/( kcat/Km)S ratio is 1/64.  The observed 
trend is the larger the substituent, the smaller the enantioselectivity.  The (kcat/Km)R/( 
kcat/Km)S ratios are 1/44 and 1/6 for compounds 2 and 3, respectively  
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 The H254G/H257W/L303T mutant contains an extended small pocket and a 
reduced large pocket.  Leu-303 in the small pocket was mutated to a comparatively 
smaller threonine residue, and the two histidines in the large pocket were changed to 
glycine and tryptophan.  The H254G/H257W/L303T (GWT) mutant displays a more 
distinct effect in the reversal of the stereoselectivity than the other mutants for the 
hydrolysis of compounds 1 and 5, with preferences for the Sp- enantiomers by a factor 
142 and 111, respectively.   
            The difference in the rate of hydrolysis for two stereoisomers of compound 5 is 
exhibited in Figure 3.2.  Figure 3.2 (A) indicates that the H254G/H257W/L303T 
(GWT)  mutant hydrolyzes one of the stereoisomers much faster than another based on 
two of the time courses for the hydrolysis of compound 5 at different concentrations of 
enzyme.  The gray dots represent the hydrolysis of the faster stereoisomer and the red 
dots indicate the hydrolysis of the slower stereoisomer.  The G60A mutant is shown to 
prefer the Rp- enantiomer of compounds 1-5 (Table 3.3).  Figure 3.2 (B) indicates that 
the H254G/H257W/L303T (GWT) mutant hydrolyzes the Sp- enantiomer of compound 
5.  The G60A mutant is added to hydrolyze the residual Rp- enantiomer.  It is shown that 
the Sp- enantiomer of compound 5 is more preferred by the H254G/H257W/L303T 
(GWT) by a factor of 111.   
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Figure 3.2  Time courses for the hydrolysis of the racemic compound 5 using the 
mutants of PTE. The total concentration of compound 5 was determined by the addition 
of KOH.  (A) The hydrolysis of compound 5 by 1.2 μM (red line) and 250 nM (gray 
line) H254G/H257W/L303T mutant of PTE.  (B)The hydrolysis of the preferred 
enantiomer (Sp) of compound 5 was hydrolyzed by 165nM H254G/H257W/L303T 
mutant of PTE. After 10 minutes, the G60A mutant of PTE was added to hydrolyze the 
Rp-enantiomer. 5 
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Discussion 
            Phosphotriesterase possesses a broad substrate selectivity and is able to detoxify 
chemical warfare agents such as GA, GB, GD, GF, and VX.  The wild-type PTE was 
demonstrated to prefer the less toxic Rp- enantiomers of the organophosphorus nerve 
agents and their analogues (45).  The preference of the wild-type PTE for compounds 1-
5 is increased by enlarging the size of the substituent of the organophosphonate 
substrates.  The G60A mutant enhances the stereoselectivity by substituting a larger 
residue in the small pocket.  It is shown to have a significant improvement in the 
(kcat/Km)R/( kcat/Km)S ratios, especially the compounds with larger substituents like 
compound 5.  This feature is utilized to isolate Sp- stereoisomers from the racemic 
mixtures, due to the fact that the G60A mutant has a faster catalytic rate for the 
hydrolysis of the Rp- stereoisomers.  
            The relaxation of stereoselectivity for compounds 1-5 was observed by some 
mutants that contain a enlarged small pocket or the leaving group pocket, such as the 
I106G and the F132G mutants.  Some mutants with an enlarged small pocket and a 
reduced large pocket relax the stereoselectivity with compound 5, such as the 
H257Y/L303T (YT) and the I106A/H257Y/S308A mutants.  The preference ratios of 
these two mutants with compound 5 are less than 3, while the wild-type prefers the Rp- 
enantiomer by a factor of 755.  The H257Y/L303T (YT) mutant prefers the Sp- 
enantiomer and the I106A/H257Y/S308A mutant prefers the Rp- enantiomer.  
            Enlargement of the small pocket and the shrinking of the large pocket 
simultaneously can alter the stereoselectivity of PTE to prefer the more toxic Sp- 
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enantiomers rather than the Rp- enantiomers.  The I106G/F132G/H257Y and the 
I106A/F132A/H257Y mutants have the highest inversion of the stereoselectivity towards 
compound 3, the I106G/F132G/H257Y mutant prefers the Sp- enantiomer by a factor of 
265 and the I106A/F132A/H257Y mutant prefers the Sp- enantiomer by a factor of 205, 
while the wild-type prefers the Rp-enantiomer with a factor of 25.  The difference in 
stereoselectivity of these mutants relative to the wild-type PTE is changed up to 6000 
fold.    
          In addition, the H254G/H257W/L303T (GWT) mutant contains a reduced large 
pocket and an enlarged small pocket, and the stereoselectivity is reversed for compounds 
1-5.  The order of preference for compounds 1-5 is not based on the size of the 
substituent for the mutant with reversed stereoselectivity, unlike the wild-type and the 
G60A enzyme.  For the hydrolysis of compound 5, the H254G/H257W/L303T (GWT) 
mutant has the highest preference for the Sp- enantiomer, the (kcat/Km)R/( kcat/Km)S ratio 
is 1/111.  Conversely, the G60A mutant prefers the Rp- enantiomer of compound 5 by a 
factor of 23,000.  This suggests that with the mutation of only four residues of PTE, the 
difference in stereoselectivity can be altered by a factor of 2.5 x 106.  In addition to the 
inversion of the enantioselectivity, the H254G/H257W/L303T (GWT) mutant possesses 
the highest catalytic activity for the more toxic Sp- enantiomers of compounds 4 and 5.  
The kcat/Km values for the hydrolysis of the SpRc- and SpSc- enantiomers of compound 4 
have been enhanced by 73 and 543 fold relative to the wild-type.  The most noticeable 
case is that the kcat/Km value for the Sp- enantiomer of compound 5 is 1340 fold higher 
than the wild-type.  
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Conclusion 
            The modification of the amino acid residues within the substrate binding site of 
PTE influences the enantiomeric selectivity significantly.  Most of the toxic 
organophosphorus nerve agents contain a chiral center.  Previous studies have shown 
that the wild-type PTE has less activity for the hydrolysis of the more toxic Sp- 
stereoisomers (84).  The G60A mutant exhibits an enhancement of stereoselectivity and 
is utilized to obtain the Sp-stereoisomers of the organophosphonates by hydrolyzing the 
Rp- stereoisomers.  The mutants containing the reversal of stereoselectivity can be 
utilized to acquire the Rp- steroisomers and enhance the hydrolysis reactivity against the 
more toxic nerve agent stereoisomers.  The more toxic Sp- entantiomers of compounds 
2-5 are not efficiently catalyzed by the wild-type PTE.  The kcat/Km values are less than 
105 M-1s-1 for the Sp- entantiomers of compounds 2 and 3, and the values are even    
smaller (less than 120 M-1s-1) for the more toxic nerve agent analogues, the Sp- 
entantiomers of compounds 4 and 5.   The selected mutants that modulate the substrate 
binding pocket are able to increase the catalytic activity for the hydrolysis of the Sp- 
entantiomers of compounds 2-5.  The wild-type PTE and selected mutants with 
increased activity towards the Sp and Rp -enantiomers of compound 2-5 are graphically 
displayed in Figure 3.3 (A) and (B), respectively.  The best mutants to hydrolyze the Sp- 
entantiomers of compounds 2 and 3 are H257Y/L303T (YT) and I106A/H257Y/S308A, 
respectively.  The kcat/Km values for these two mutants are enhanced to more than 105    
M-1s-1.  The increase in the catalytic activity is 4-fold and 11-fold relative to the wild-
type with the Sp- entantiomers of compounds 2 and 3, respectively.  The 
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H254G/H257W/L303T (GWT) mutant has the highest activity for the hydrolysis of the 
more critical organophosphorus nerve agent (soman and cyclosarin) analogues, 
compounds 4 and 5.  The kcat/Km values are enhanced to approximately 103 M-1s-1 for the 
SpSc- entantiomer of compound 4 and are around 104 M-1s-1for the SpRc- entantiomer of 
compound 4 and the Sp- entantiomer of compound 5.  The enhancements are 540-fold 
for the Sp- entantiomers of compound 4 and 1340-fold for the Sp- entantiomer of 
compound 5.  These results suggest that the mutations in the active site based on the 
beneficial mutant as the template would be capable of reaching higher activities for these 
organophosphonates compounds and organophosphorus nerve agents.  
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Figure 3.3  Bar graphs illustrating increased values of kcat/Km for the Sp- (A) and the Rp- 
(B) enantiomers of compounds 2, 3, 4, and 5 catalyzed by the wild-type and mutants of 
PTE.  The numbers represent the increase and decreasein activity relative to the wild-
type enzyme.                          
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CHAPTER IV 
ENGINEERING PHOSPHOTRIESTERASE FOR THE ENHANCEMENT OF 
STEREOSELECTIVITY TOWARDS NERVE AGENT ANALOGUES 
 
Introduction 
            Protein engineering is a powerful tool to improve the functions of enzymes, such 
as catalytic activity, stability under certain conditions, protein expression levels, and 
stereoselectivity.  For example, the stereoselectivity of enzymes can be enhanced or 
reversed for use in synthetic organic chemistry, unnatural substrate decomposition and 
unnatural product production.  The reactivity of the hydantoinase from E. coli for D-5(2-
methylthioethyl) hydantoin is higher than for the L-enantiomer.  Hydantoinase mutants 
with inverted stereoselectivity and high D-selectivity were discovered by directed 
evolution (99).  Thus whole-cell catalysts for efficient production of chiral compounds 
can be improved by introducing stereoselective enzymes into multienzyme pathways.  
The wild-type hydantoionase has a ~40% eeD and a mutant with enhanced selectivity has 
a 90% eeD.  A mutant that inverted the stereoselectivity was increased 5-fold for 
conversion of the substrate but has only ~20% eeL.   The selectivity of E. coli D-sialic 
acid aldolase was reversed to catalyze the formation of the unnatural sugar L-3-deoxy-
manno-2-octulosonic acid (L-KDO).  The best mutant exhibits a >1,000-fold preference 
for L-KDO relative to the D-sialic acid (100).  An epoxide hydrolase from Aspergillus 
niger was engineered to increase stereoselectivity.  The wild-type epoxide hydrolase 
prefers to produce the S-enantiomer of glycidyl phenyl ether 4.6-fold higher than the R-
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enantiomer (E = 4.6) from 2-phenoxyoxirane.  The best mutant was discovered by 
directed evolution and shown to have an enhanced stereoselectivity (E = 115).  This 
could be a useful tool in asymmetric catalysis.  
           The bacterial phosphotriesterase (PTE) from Psuedomonase diminuta is an 
enzyme that can detoxify a wide range of organophosphate insecticides and chemical 
warfare agents, including tabun (GA), sarin (GB), soman (GD), cyclosarin (GF) and VX 
(Scheme 4.1) (58).  The catalytic ability of PTE for the hydrolysis of paraoxon is close 
to the diffusion-control limit (kcat/Km ~ 108 M-1 s-1) (3).  The stereoselectivity of the 
wild-type PTE towards GB, GD, GF, VX and rVX analogues was presented in Chapter 
III.  The wild-type PTE generally shows higher activity and substrate specificity for the 
Rp-enantiomers.   However, the Sp-enantiomers of these nerve agents are more toxic than 
the Rp-enantiomers (48).  PTE mutants with reversed stereoselectivity were identified 
and shown to have enhanced catalytic ability to hydrolyze the more toxic Sp-
enantiomers.    
            Directed evolution and rational design of phosphotriesterase for the enhancement 
of hydrolysis activity towards organophosphate compounds have been studied by several 
laboratories.  Wilfred Chen and coworkers created a randomized library of PTE by DNA 
shuffling and saturation mutagenesis.  The library of PTE mutants was displayed on the 
surface of E. coli cells and the beneficial mutants were isolated by a solid-phase top agar 
assay.  They discovered that some distal mutations, such as K185R and I274N, are 
important for improvement of the hydrolysis activity toward paraxon, parathion,  
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Scheme 4.1  The chemical structure of paraoxon, tabun (GA), sarin (GB), soman (GD), 
cyclosarin (GF), VX and rVX. 
          
chlorpyrifos and coumaphos (28, 101).  Dan Tawfik and colleagues also utilized DNA 
shuffling to construct randomized PTE libraries.  The libraries were transformed and 
screened with 2-naphthyl acetate on LB agar plates or screened by an in vitro 
compartmentalization technique.  PTE variants with enhanced stability in the metal-free 
state and increased hydrolysis activity toward paraoxon were discovered.  The S5 mutant 
that contains three mutations beyond the substrate binding pocket (K185R, D208G and 
R319S) was shown to have a 20-fold increase in protein expression (33).   
             The organophosphate degrading enzyme OpdA from Agrobacterium radiobacter 
P230, has 90% sequence identity with PTE, and was modified by David Ollis and 
collaborators.  OpdA and PTE libraries were created by error-prone PCR and DNA 
shuffling.  The cells with transformed libraries were grown on paraoxon with indicator 
plates.  The variants were selected and shown to have improved protein expression and 
slightly better activity towards methyl-paraoxon, methyl-parathion and demeton-S.  
                                                                                             
96
These mutants contain some alternations on the surface of the protein.  They suggested 
that these mutations might contribute to protein stability (31, 32).  
            Single and double substitution libraries contain 20 and 400 protein variants, 
respectively.  The screening of these small libraries can be conducted by growing single 
colonies in 96 deep-well growth blocks cultures and screened with selected substrates.  
A high throughput in vivo selection technique that incorporated a new phosphate 
assimilation pathway was utilized to isolate the active PTE variants when the sizes of the 
randomized libraries are large (> 1,000 variants).  In a previous study, the in vivo assays 
that have glycerophosphodiesterase (GpdQ) from Enterobacter aerogenes and PTE 
coexpressed in E. coli cells indicated that cells could grow by utilizing the 
organophosphate and organophosphonate esters as the sole phosphorus source (102).  In 
E. coli cells, PTE can hydrolyze a wide range of organophonate esters to methyl 
phosphonate esters, GpdQ can subsequently hydrolyze the methyl phosphonate esters to 
produce methyl phosphonate.  The C-P lyase complex that belongs to the phn operon in 
E. coli can metabolize methyl phosphonate to inorganic phosphate and methane (103, 
104).  The proposed phosphate assimilation catabolic pathway is presented in Scheme 
4.2.  
Scheme 4.2  Proposed catabolic pathway of organophosphonate esters. 
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            In this chapter, directed evolution and rational design of PTE were utilized based 
on the active mutants of the first generation of mutants as templates.  More active 
mutants toward the hydrolysis of the toxic Sp-enantiomers of organophosphate nerve 
agent analogues were discovered.  Kinetic parameters of the wild-type and mutants of 
PTE towards the chiral analogues of GB, GD, GF, VX, and rVX with a 4-acetylphenol 
leaving group (Scheme 4.3) were characterized.  X-ray crystal structures of the mutants 
in the second generation were determined.  
 
Scheme 4.3  Chemical structures of organophonate nerve agent analogues. 
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Materials and Methods 
Site-Directed Mutagenesis.   The A80V, K185R and I274N mutations of the 
wild-type PTE were created by the QuikChange site directed mutagenesis technique 
using pfu Turbo DNA polymerase from Stratagene.  The oligonucleotide pairs that 
contained the mutated codon at a specific site were used as the primers to amplify the 
wild-type, the H254Q/H257F (QF), H257Y/L303T (YT) and the H254G/H257W/L303T 
(GWT) mutants by PCR.  DpnI was used to digest the parental DNA plasmids without 
the mutated codon.  The digested PCR products were transformed into E. coli XL1-blue 
electro-competent cells for DNA sequencing.  The mutations were added to the template 
sequentially.  Thus, the RN (K185R/I274N), the QFRN (H254Q/H257F/ K185R/I274N), 
the YTRN (H257Y/L303T/K185R/I274N), the GWT-d1 (H254G/H257W/L303T/ 
K185R/I274N) and the GWT-d2 (H254G/H257W/L303T/ K185R/I274N/A80V) 
mutants were created.  
Construction of Single and Double Substitution PTE Libraries. The single 
substitution library, M317X, and the double substitution libraries, W131X/F132X, 
S308X/Y309X and L271X/S308X, of PTE were created using the gene for GWT-d1 
(H254G/H257W/L303T/K185R/I274N) as the initial template for QuikChange 
mutagenesis. The primers contained the degenerate codon NNS at the targeted position 
to eliminate two stop codons, TGA and TAA (N = A, T, G, C; S = C, G).  The M317X, 
W131X/F132X, F306X/Y309X and S308X/Y309X libraries were created using one pair 
of primers.  The I106X/S308X library was made using the degenerate primers at the 
Ile106 site to perform the first round of QuikChange mutagenesis.  Colonies from the 
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I106X library were collected and plasmids from this library were isolated for the second 
round of QuikChange mutagenesis using the primers with the degenerate codon at the 
Ser-308 site.   The double substitution libraries, C59X/S61X and I255X/W302X, were 
constructed using the GWT-d2 (H254G/H257W/L303T/K185R/I274N/A80V) mutant as 
the template. The degenerate primers targeted for the Cys-59 and Ser-61 sites were for a 
single round of QuikChange mutagenesis.  Two pairs of primers that contain the 
degenerate codon at the Ile-255 and the Trp-302 sites were utilized for QuikChange 
mutagenesis sequentially.  PCR products were transformed into E. coli BL21 (DE3) cells 
for DNA sequencing and protein expression.   
Construction of a Multisite Randomized PTE Library.  A PTE library was 
constructed using the gene for the GWT-f1 
(H254G/H257W/L303T/M317L/K185R/I274N) mutant as the template.  Six residues in 
the substrate binding pocket were randomized, including Ile-106, Phe-132, Leu-271, 
Phe-306, Ser-308 and Tyr-309.  The randomized residues at these six sites were selected 
from the results of screening 228 single site PTE mutants towards the hydrolysis of 
paraoxon (unpublished data).  The randomized residues for the Ile-106 site are Ala, Cys, 
Gly, Ile, Met and Val. The randomized residues for the Phe-132 site are Ala, Cys, Phe, 
Gly, His, Ile, Leu, Pro, Arg, Ser, Thr, Val and Tyr.  The randomized residues for the 
Leu-271 site are Phe, Ile, Leu, Tyr and Gln.  The randomized residues for the Phe-306 
are Phe, Ile, Leu and Met.  The randomized residues for the Ser-308 site are Ala, Cys, 
Gly, Ser, Thr, Glu, Leu, Gln, Val and Asn.  The randomized residues for the Tyr-309 
sites are Ala, Cys, Asp, Phe, Gly, Leu, Asn, Ser, Thr, Val, Tyr and Trp.   
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Scheme 4.4  The creation of six site randomized library of PTE. 
 
  This multisite randomized PTE library was constructed by combining five 
segments of the gene for PTE.  These five segments of the PTE gene were amplified 
using the primers shown in Table 4.1.  Scheme 4.4 shows the five segments of the PTE 
gene.  The first segment was amplified using primers 1 and 2 from Table 4.1.  The 
mixture of the genes for I106A, I106C, I106G, I106M, and I106V mutants, and the wild- 
type PTE was served as the initial template.  The genes for I106A, I106C, I106G, I106M 
and I106V mutants were previously made and they were mixed with the gene for the 
wild-type PTE in approximately equal concentrations.  The second segment was 
amplified using primers 3 and 4 from Table 4.1.  The mixture of genes for I132A, 
I132C, I132F, I132G, I132H, I132L, I132P, I132R, I132S, I132T, I132V, and I132T  
mutants, and the wild-type PTE was served as the initial template.  The genes for I132A, 
I132C, I132F, I132G, I132H,I132L, I132P, I132R, I132S, I132T, I132V and I132T 
mutants were previously made, and they were mixed with the gene for the wild-type 
PTE in approximately equal concentrations. The third segment was amplified using 
primers 5 and 6, and the gene for the GWT-f1 mutant was used as the template.  The 
fourth segment was amplified using the combination of primers 7, 8 and 9 as the forward 
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primer, and primer 10 as the backward primer using the gene of GWT-f1 mutant as the 
template.  The fifth segment was amplified using the combination of primers 11, 12, 13, 
14, 15 and 16 as the forward primer, and primer 17 as the backward primer using the 
gene of GWT-f1 mutant as the template.   
             Primer 7 encodes three residues (F, I, L) for residue 271.  Primer 8 encodes 
tyrosine for residue 271.  Primer 9 encodes glutamine for residue 271.  The forward 
primer for the amplification of the fourth segment was mixed with primers 7, 8 and 9 to 
residues (A, C, D, G, N, S, T, and Y) for residue 309.  Primer 12 encodes four residues 
(F, I, L, and M) for residue 306, four residues (E, L, Q, and V) for residue 308, and eight 
residues (A, C, D, G, N, S, T, and Y) for residue 309.  Primer 13 encodes four residues 
(F, I, L, and M) for residue 306, one residue (N) for residue 308, and eight residues (A, 
have equal concentration for each genotype. Primer 11 encodes four residues (F, I, L, 
and M) for residue 306, five residues (A, C, G, S, and T) for residue 308, and eight C, D, 
G, N, S, T, and Y) for residue 309.  Primer 14 encodes four residues (F, I, L, and M) for 
residue 306, five residues (A, C, G, S, and T) for residue 308, and six residues (C, F, G, 
L, V, and W) for residue 309.  Primer 15 encodes four residues (F, I, L, and M) for 
residue 306, four residues (E, L, Q, and V) for residue 308, and six residues (C, F, G, L, 
V, and W) for residue 309. Primer 16 encodes four residues (F, I, L, and M) for residue 
306, one residue (N) for residue 308, and six residues (C, F, G, L, V, and W) for residue 
309.  The forward primer for the amplification of the fifth segment was mixed with 
primers 11, 12, 13, 14, 15 and 16 to have equal concentration for each genotype.  
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Table 4.1 Sequences of the primers for creating the six sites randomized library. 
 
No. Name Sequences of primers 
1 NdeI-pJames 5’ (+)   5’-CCC GCG GGG CAT ATG TCC ATC GGG ACC GGT GAC CGT ATC-3’   
2 130-121 pJames (-)  5’-CAG ACC GGT AGC AGC AAC GAT GTG TAC ATC -3’ 
3 108-118 pJames (+) 5’- CGT GAC GTT TCC CTG CTG GCT GAA GTT TCC C -3’ 
4 182-174 pJames(-) 5’-C GAG CTC CTG GAA CGG GGT AGC TTT ACC-3’   
5 134-142 pJames (+) 5’-CCG CCG CTG AGC ATG CGT CTG CGT TCC -3’ 
6 270-259 pJames (-) 5’- C GGA AGC GGA TGC ATT GTC TTC CAG ACC GAT AGC -3’ 
7 L271(FIL)-pJames(+) 
5’- C GGT CTG GAA GAC AAT GCA TCC GCT 
TCC GCT HTC CTG GGT AAT CGT TCC TGG C 
-3’ 
8 L271(Y)-pJames(+) 
5’- C GGT CTG GAA GAC AAT GCA TCC GCT 
TCC GCT TAC CTG GGT AAT CGT TCC TGG C 
-3’ 
9 L271(Q)-pJames(+) 
5’- C GGT CTG GAA GAC AAT GCA TCC GCT 
TCC GCT CAG CTG GGT AAT CGT TCC TGG C 
-3’ 
10 305-291 pJames (-) 5’- CC GAA AGT CCA GTC GTT GGA AAC CAA GAT CTG TTT CAT GTA ACC -3’  
11 F306(4)S308(5)Y309(8) pJames(+) 
5’- CC AAC GAC TGG ACT TTC GGT HTS TCG 
DSC DVC GTT ACC AAC ATC ATG GAC GTT 
TTG GAC C -3’ 
12 F306(4)S308(4)Y309(8)pJames(+) 
5’- CC AAC GAC TGG ACT TTC GGT HTS TCG 
SWG DVC GTT ACC AAC ATC ATG GAC GTT 
TTG GAC C -3’ 
13 
F306(4)S308(N)Y30
9(8)pJames(+) 
 
5’- CC AAC GAC TGG ACT TTC GGT HTS TCG 
AAC DVC GTT ACC AAC ATC ATG GAC GTT 
TTG GAC C -3’ 
14 F306(4)S308(5)Y309(6)pJames(+) 
5’- CC AAC GAC TGG ACT TTC GGT HTS TCG 
DSC KKS GTT ACC AAC ATC ATG GAC GTT 
TTG GAC C -3’ 
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Table 4.1 Continued 
 
Note: The symbol S, K, W, H, D and V in the sequences of the primers represents 
different mixture of bases.  (K= G, T; S= C, G; W= A, T; H= A, C, T; D= A, G, T; V=A, 
C, G) 
 
 
 
 
 
 
 
 
 
 
 
 
15 
F306(4)S308(4)Y30
9(6)pJames(+) 
 
5’- CC AAC GAC TGG ACT TTC GGT HTS TCG 
SWG KKS GTT ACC AAC ATC ATG GAC GTT 
TTG GAC C -3’ 
16 
F306(4)S308(N)Y30
9(6)pJames(+) 
 
5’- CC AAC GAC TGG ACT TTC GGT HTS TCG 
AAC KKS GTT ACC AAC ATC ATG GAC GTT 
TTG GAC C -3’ 
17 AvrII –pJames 3’ (-) 5’-CCC CCT AGG TCA TCA TCA GGA AGC ACG CAG GGT C -3’ 
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            These five segments of PTE gene were overlapped by primerless PCR for 15 
cycles. The whole PTE gene with six randomized sites was amplified by PCR for 55 
cycles using primer 1 and primer 17.  Thus, the multisite randomized PTE library, 
I106(6)/ F132(13)/ L271(5)/ F306(4)/ S308(10)/Y309(12), was created; the numbers in 
the parentheses represent the numbers of possible residues in each site.  The potential 
size of this library is 1.87 X 105 variants.  The amplified PTE library was digested with 
NdeI and AvrII restriction enzymes and ligated into the NdeI and AvrII digested GpdQ-
pETDuet plasmid using T4 DNA ligase from Roche.  The overnight ligation of the PTE 
library –GpdQ/pETDuet was purified by the QIAquick Kit to remove salts in the T4 
DNA ligase buffer and transformed into fresh-made E. coli Top 10 competent cells.  The 
transformants were incubated at 37 °C for an hour and then plated on LB-ampicilin 
agarose.  The colony forming units (CFU) were counted and reached 3-fold of the library 
size.  All of the CFU were collected together and grown in LB culture for 6 hours at 37 
°C.  The plasmids from the PTE library –GpdQ-pETDuet were extracted using the 
Promega Wizard® Plus Miniprep kit. 
Construction of PTE Library by Error Prone PCR.  Random mutagenesis PCR 
was performed by error-prone PCR using Mutazyme II DNA polymerase® from the 
Gene-Morph II system (Stratagene).  The gene for the GWT-f4 mutant served as the 
template.  The amount of template was 90 ng in each reaction for the generation of 1.5 
mutations per 1,000 kb gene.  The amplified PTE library and the GpdQ-pETDuet 
plasmids were digested by NdeI and AvrII restriction enzymes and ligated into GpdQ-
pETDuet plasmid using T4 DNA ligase buffer. The library was transformed into fresh E. 
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coli Top10 competent cells. The transformants were incubated at 37 °C for an hour and 
plated on LB-ampicilin agarose.  The colony forming units were counted to estimate the 
library size.   Approximately 6 X 105 cells were collected together to grow in LB 
cultures for 6 hours at 37 °C.  The plasmids of the PTE library/GpdQ-pETDuet were 
extracted using a Promega Wizard® Plus Miniprep kit. 
           Growth Assays.  The gene for GpdQ was inserted into the first T7 promoter 
position of the pETDuet plasmid and the wild-type and mutants of PTE was inserted into 
the second T7 promoter position.  The PTE/GpdQ-pETDuet plasmids were transformed 
into E. coli BL21 (DE3) competent cells and grown on LB plates containing 0.1 μg/mL 
ampicilin.  The colonies from fresh transformations were inoculated and grown 
overnight in super broth medium at 30 °C.  Overnight cultures were washed four times 
with sterile ddH2O to remove any traces of the rich medium.  A 20 mL liquid MOPS 
phosphate-free minimal medium culture was inoculated with 2% fresh and previously 
washed overnight culture.  The MOPS minimal medium, pH 7.4 was supplemented with 
0.1% glucose as the carbon source, and 0.1 μg/mL thiamin (XY).  Various 
organophosphonate compounds were added to the cultures to a final concentration of 1.0 
mM. As control experiments, PTE-/GpdQ- BL21 (DE3) cells were grown in the 
presence and absence of inorganic phosphate.  PTE+/ GpdQ+ BL21 (DE3) cells were 
induced by 0.5 mM IPTG for protein expression.  Cell growth was monitored by 
measuring the OD600 for 5-10 days at 30 °C. 
Screening of the Single and Double Substitution Libraries. The products of 
QuikChange mutagenesis were transformed into E. coli. BL-21 competent cells and 
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inoculated in 96-deep well culture blocks containing 1 mL super broth (SB) 
supplemented with 0.5 mM CoCl2 and 0.1 μg/mL ampicillin.  Variants of the M317X 
library in the culture blocks were screened with paraoxon and the Sp-enantiomer of 
compound 5 containing 2% Bug Buster in the mixture of the assays.  Variants of the 
C59X/S61X library in the culture blocks were screened with paraoxon and the Sp-
enantiomers of compound 4 containing 2% Bug Buster in the mixture of the assays.  The 
para-acetyl phenol leaving group of the Sp-enantiomers of compounds 4 and 5 was 
replaced with para-nitrophenol.  The production of the hydrolysis products of paraoxon 
and the Sp-enantiomers of compounds 4 and 5 were measured by monitoring the 
formation of para-nitrophenol at 400 nm (ε400= 17,000 M-1 cm-1) in 50 mM CHES, pH 
9.0 buffer using a SpectraMax plate reader (Molecular Devices Inc., Sunnyvale, CA) at 
30 °C.  
In vivo Selection on Phosphate Free MOPS Minimal Medium Plates.  The PTE 
library-GpdQ-pETDuet plasmids were transformed into E. coli BL21 (DE3) cells and 
plated on LB-ampicilin agarose.  The cells were collected and grown in super broth (SB) 
medium at 30 °C for 12 hours.  The cells were washed for four times with sterile ddH2O 
to remove any traces of the rich medium.  The cells were plated on MOPS phosphate-
free minimal medium agarose with 0.4 μg/mL ampicilin and 0.5 mM IPTG.   After 7-10 
days growth at 30 °C, the colonies with sizes larger than the background were selected.  
The first round of selection used the GWT-f2 mutant as the background and the second 
round used the GWT-f4 mutant as the background.  Approximately 5.8 X 105 colonies 
from the multisite-randomized PTE library and approximately 6 X 105 colonies from the 
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error prone PTE library were collected and inoculated onto LB-ampicilin plates.  The in 
vitro screening assays for the hydrolysis activity for paraoxon and the Sp- enantiomer of 
compound 5 were conducted to identify relative activities compared with wild-type PTE 
and the template mutant.  
Expression, Growth and Preparation of Phosphotriesterase.  The mutant 
phosphotriesterase plasmids were transformed into E. coli BL-21 cells.  The transformed 
BL-21 cells were grown in Luria-Bertani (LB) broth overnight at 37 °C.  The overnight 
cultures were used to inoculate 1L Terrific Broth (TB) containing 25 µg/mL ampicilin 
and 1.0 mM CoCl2 at 30 °C. The expression of PTE was induced by the addition of 1.0 
mM  IPTG when the OD600 reached 0.4.  The cells were harvested at 4 °C by 
centrifugation at 6,000 rpm after allowing the culture to reach stationary phase after 36-
42 hours at 30 °C.   The cells were harvested by centrifugation at 6,000 rpm for 15 
minutes at 4 °C.  The wet cell pellet was isolated and stored at -78 °C until needed.  
Purification of Phosphotriesterase.  The mutant proteins were purified from E. 
coli BL21 cells according to the previously reported protocols (38).  The fractions were 
pooled based on enzymatic activity, absorbance at 280 nm and the molecular weight 
determined by SDS PAGE.  The progress of the purification procedure was monitored 
by determining the specific activity and analysis with SDS-polyacrylamide gels. 
(Omburo et al., 1992) 
Kinetic Measurements and Data Analysis.  The kinetic constants for each 
substrate were determined by monitoring the production of para-acetylphenol at 294 nm 
(ε294= 7,710 M-1 cm-1) in 50 mM CHES, pH 9.0, buffer using a SpectraMax plate reader 
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(Molecular Devices Inc., Sunnyvale, CA) at 30 °C.  Protein concentration in crude 
samples was determined by measuring the absorbance at 280 nm.  The kinetic constants 
(kcat and kcat/Km) were obtained by fitting the data to equation (1), where v is the initial 
velocity, kcat is the turnover rate, [A] is the concentration of substrate, Et is the enzyme 
concentration, and Km is the Michaelis constant.  
                                                v / Et = kcat [A] / (Km + [A])                                          (4.1) 
            X-ray Structure Determination and Refinement.  The crystallization, structural 
determination and refinement of the PTE mutants, QFRN, GWT-d3 and GWT-f5 were 
conducted by Mr. Nicolas Fox.  The works for the H254Q/H257F mutant was performed 
by Dr. Jungwook Kim. 
 
Results 
             Expression of PTE with K185R and I274N Mutations.  SDS-PAGE analysis of 
the soluble portions of the cell lysate for the H254G/H257W/L303T mutant and the 
GWT-d1 mutant (H254G/H257W/L303T/ K185R/I274N) are shown in Figure 4.1.  The 
protein expression level and the soluble portion of the GWT-d1 mutant are slightly 
greater than the H254G/H257W/L303T (GWT) mutant.  The amount of protein that has 
can be obtained from purification of the GWT-d1 mutant is 10-fold higher than the 
H254G/H257W/L303T (GWT) mutant.  The addition of the K185R and I274N 
mutations to the wild-type PTE and other mutants help to increase the expression and 
protein yields by 2- to 10-fold.  This suggests that the K185R and I274N mutations 
enhance net protein expression and solubility of PTE.  
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Figure 4.1  SDS-PAGE gels of crude cell lysate of the H254G/H257W/L303T mutant 
(A) and the GWT-d1 (H254G/H257W/L303T/K185R/I274N) mutant (B).  The first 
lanes are standard PTE, the second lanes are cell lysate, and the third lanes are collected 
from the supernatant after the centrifugation of cell lysate.  
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Discovery of Variants towards the Sp- GF Analogue by Screening the Single and 
Double Substitution Libraries. The H254G/H257W/L303T mutant was previously 
shown to have the highest activity for the hydrolysis of the more toxic Sp- enatiomers of 
soman (GD) and cyclosarin (GF) analogues.  The K185R and I274N mutations of PTE 
can increase protein expression and solubility.  Hence, libraries were constructed using 
the GWT-d1 mutant (H254G/H257W/L303T/K185R/I274N) as the template to discover 
more active PTE variants for the hydrolysis of the Sp- enantiomers of compounds 4 and 
5.  The 9 amino acid residues other than positions 254, 257 and 303 in the substrate 
binding pocket were considered as “hot spots” to be randomized for the construction of 
PTE libraries.  The single substitution library of PTE, M317X was therefore constructed.   
The double substitution libraries, W131X/F132X, F306X/Y309X, S308X/Y309X, and 
I106X/Y308X, which have two residues randomized were also constructed.   Six 
colonies from each library were selected randomly to confirm that the sites were 
randomized at the targeted positions (Table 4.2).  Around 60 colonies from the single 
substitution library and around 550 colonies from the double substitution libraries were 
picked and grown in the super broth culture, and screened with the Sp- enantiomer of 
compound 5.  The variants with higher activity than the background from the first round 
of screening were isolated and rescreened with the same substrate.  The W131X/F132X, 
the F306X/Y309X, the S308X/Y309X and the I106X/Y308X libraries were shown to 
have no any significant improvement towards the hydrolysis of the Sp- enantiomer of 
compound 5.  Figure 4.2 (A) is an example of the screening of the double substitution 
library, W131X/F132X.  The first 10 samples comprise the following controls: BL21  
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Table 4.2  Sequence identifications of the PTE variants from the M317X, 
W131X/F132X, F306X/Y309X, S308X/Y309X and I106X/S308X libraries using the 
gene for the GWT-d2 mutant as the template.  
 
ID of  the 
M317X library 
Mutations at the 
targeted sites 
1 M317H 
2 M317F 
3 M317P 
ID of  the 
W131X/F132X 
library 
Mutations at the 
targeted sites 
ID of  the  
F306X/Y309X 
library 
Mutations at the 
targeted sites 
1 W131P/F132Q 1 F306R/Y309Q 
2 W131I/F132K 2 Y309H 
3 W131A/F132E 3 F306Y/Y309A 
4 W131D/F132N 4 F306W/Y309G 
5 W131H/F132A 5 F306V/Y309L 
6 W131N/F132P 6 F306F/Y309T 
ID of  the   
S308X/Y309X 
library 
Mutations at the 
targeted sites 
ID of  the   
I106X/S308X 
library 
Mutations at the 
targeted sites 
1 S308L/Y309H 1 I106V/S308F 
2 S308G/Y309N 2 I106S/S308Q 
3 S308M/Y309G 3 I106L/S308T 
4 S308T/Y309K 4 I106G 
5 S308C/Y309K 5 I106A/S308L 
6 S308Q/Y309S 6 S308C 
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Figure 4.2  Screening of the (A) W131X/F132X and (B) M317X mutant libraries 
against the Sp- enantiomer of compound 5 using the GWT-d1 mutant 
(H254G/H257W/L303T/K185R/I274N) as the template.  The W131X/F132X library in 
(A) was the second round of screening.  The colonies were selected from the first round 
with positive results.  
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(DE3) containing pET20b (black), WT PTE (pink), RN PTE (red), GWT PTE (blue), 
and GWT-d1 PTE (GWTRN) (light green).  This is the second round of screening that 
selected the samples with positive results from the first round.  The W131X/F132X 
mutant library did not have beneficial variants towards the Sp- enantiomer of compound 
5.  Figure 4.2 (B) displays the screening of the single substitution library, M317X, the 
first 12 samples comprise the following controls: BL21 (DE3) containing pET20b 
(black), WT PTE (pink), GWT PTE (cyan), and GWTRN PTE (light green).  The GWT-
f1 mutant (H254G/H257W/L303T/M317L/K185R/I274N) from the M317X library was 
isolated and shown to have a 1.5-fold enhancement in a normalized rate compared to the 
template GWT-d1 mutant by screening with the Sp- enantiomer of compound 5.  The 
colony with the background sequence for the GWT-d1 mutant was isolated.  They were 
shown to have similar normalized rate to the GWT-d1 PTE control toward the Sp- 
enantiomer of compound 5.   
            The purified GWT-f1 mutant was shown to have slightly better activity towards 
the Sp- enantiomer of compound 5 than the H254G/H257W/L303T mutant.  QuikChange 
mutagenesis was performed to change the K185R and the I274N mutations of GWT-f1 
back to lysine and isolucine, respectively.  The activity for the hydrolysis of the Sp- 
enantiomer of compound 5 of the purified GWT-f2 mutant 
(H254G/H257W/L303T/M317L) is higher activity than the GWT-f1 mutant.  
            Discovery of Active Variants towards the Sp- GD Analogue by Screening Double 
Substitution Libraries.  The 12 amino acid residues in the substrate binding pocket were 
chosen for double substitution libraries using the GWT-d1 mutant 
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(H254G/H257W/L303T/K185R/I274N) as the template. The W131X/F132X, 
F306X/Y309X, S308X/Y309X and I106X/Y308X libraries were screened with  
the Sp- enantiomers of compound 4, but no beneficial variants were discovered. The 
A80V mutation was reported to have improved the expression of PTE in E. coli cells 
(31).  This mutation was added to the GWT-d1 mutant using QuikChange mutagenesis.  
The GWT-d2 mutant (H254G/H257W/L303T/K185R/I274N/A80V) was shown to have 
a slightly better protein expression level and a higher activity towards the Sp- enantiomer 
of compound 4 than the GWT-d1 mutant.  Double substitution libraries that randomize 
the residues close to the substrate binding pocket were created.  The I255X/W302X and 
C59X/S61X libraries were constructed using the GWT-d2 mutant as the template. Six 
colonies from each library were selected to determine that the targeted positions were 
randomized (Table 4.3).  For each double substitution library, around 600 colonies were 
picked and grown in the super broth culture and screened with the Sp- enantiomers of 
substrate 4.   Figure 4.3 (A)(B) shows the results for the second round of screening of 
the I255X/W302X and C59X/S61X libraries.  These colonies were selected from the 
samples with positive results in the first round.   The first 6 samples comprise the 
following controls: BL21 (DE3) containing pET20b (black), WT PTE (pink), and 
GWTRNV PTE (light green).  The H254G/H257W/L303T/K185R/I274N/A80V/I255A 
mutant from the I255X/W302X library and the 
H254G/H257W/L303T/K185R/I274N/A80V/C59F mutant from the C59X/S61X library 
were shown to have a slightly higher normalized rate than the starting template against 
the Sp- enantiomers of compound 4.  However, the purified mutants,  
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Table 4.3  Sequence identifications of the PTE variants from the I255X/W302X and the 
C59X/S61X libraries using the gene for the GWT-d2 mutant as the template.  
 
ID of  the 
I255X/W302X 
library 
Mutations at the 
targeted sites 
1 I255R/W302R 
2 I255L/W302A 
3 I255M 
4 I255S/W302Q 
5 I255T/W302G 
6 I255P/W302R 
ID of  the 
C59X/S61X 
library 
Mutations at the 
targeted sites 
1 C59F 
2 C59L 
3 C59V/S61T 
4 C59Y/S61K 
5 C59N/S61F 
6 C59I/S61L 
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Figure 4.3  Screening of the I255X/W302X (A) and C59X/S61X (B) mutant libraries 
against the Sp- enantiomers of compound 4 using the GWT-d2 mutant 
(H254G/H257W/L303T/K185R/I274N/A80V) as the template.  These are the second 
round of screening.  The colonies were chosen from the samples with positive results in 
the first round of screening.  
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H254G/H257W/L303T/K185R/I274N/A80V/I255A and 
H254G/H257W/L303T/K185R/I274N/A80V/C59F, did not have an enhanced activity 
towards the Sp- enantiomers of compound 4.  The GWT-d3 
(H254G/H257W/L303T/K185R/I274N/A80V/S61T) mutant was isolated and shown to 
have a 1.3-fold enhancement in the normalized rate compared to the template mutant, 
GWT-d2, by screening with the Sp- enantiomers of compound 4 (Figure 4.3 (B)).  The 
purified GWT-d3 mutant displays the highest activity towards the Sp- enantiomers of 
compound 4. 
            Growth of E. coli Coexpressing PTE and GpdQ.  The growth of GpdQ+ cells in 
the phosphate free MOPS minimal medium in the presence of phosphonate esters was 
tested in previous studies.  The growth rate of the cells was proportional to the catalytic 
efficiency of GpdQ towards the phosphonate substrates (102).  The growth rate of the 
GpdQ+/PTE+ cells is related to the catalytic activities of PTE and GpdQ towards the 
organophosphonate diesters and methyl phosphonate monoesters, respectively.  
Different PTE mutants have different expression levels and thus the intracellular 
concentration of PTE is also associated with cell growth.  In Figure 4.4, PTE and GpdQ 
coexpressed E. coli BL21 (DE3) cells were grown in the phosphate free MOPS minimal 
medium using the Sp-enantiomer of compounds 2 and 3 as the phosphorus source. The 
OD600 was measured for about 125 hours to observe cell growth.  According to Chapter 
III and Table 4.6 and 4.7, the wild-type PTE has a slower hydrolysis rate towards the Sp- 
enantiomers of compound 2 and 3 relative to the Rp- enantiomers.  The H257Y/L303T  
                                                                                             
118
Time (hour)
0 10 20 30 40 50 60 70 80 90 100 110 120 130
O
D
60
0
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
 
 
 
 
Figure 4.4  Time courses for the growth of GpdQ+/wild-type PTE in the presence of Sp-
2 (▓), GpdQ+/wild-type PTE in the presence of Sp-3 (▲), GpdQ+/ mutant PTE 
(H257Y/L303T) in the presence of Sp-2 (◇), GpdQ+/ mutant PTE 
(I106A/H257Y/S308A) in the presence of Sp-3 (◆), the control experiments are cells E. 
coli BL21 (DE3) in the presence of inorganic phosphate (○), methyl phosphonate(▼), 
and no phosphate source(●).   
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(YT) and the I106A/H257Y/S308A (AYA) mutants were shown to have higher activity 
in both kcat and kcat/Km values towards the Sp-enantiomers of compound 2 and 3, 
respectively.  The growth curves of GpdQ+/ wild-type PTE+ cells did not show any 
enhancement within 125 hours.  However, the cells of GpdQ+/ YT-PTE growing on the 
Sp-enantiomer of compound 2 show a lag phase of approximately 70 hours and the cells 
of GpdQ+/ AYA-PTE growing on the Sp-enantiomer of compound 3 show a lag phase of 
50 hours.  Previous studies have shown that the kcat/Km value of GpdQ against O- 
isobutyl methyl phosphonate (the hydrolysis product of compound 3) is 66-fold higher 
than O-isopropyl methyl phosphonate (the hydrolysis product of compound 2).  In 
addition, the kcat/Km value of the I106A/H257Y/S308A (AYA) mutant towards the Sp-
enantiomer of compound 3 is 3.9 x 105 M-1s-1, and  the kcat/Km value of the 
H257Y/L303T (YT) mutant towards the Sp-  enantiomer of compound 2 is 1.1 x 105 M-
1s-1.  The growth rates of GpdQ+/ YT-PTE with the Sp-enantiomer of compound 2 and 
GpdQ+/ AYA-PTE with the Sp-enantiomer 3 were influenced by the hydrolysis activity 
of mutant PTE towards the organophosphonates and GpdQ toward the phosphonates.  
Thus, the lag phase for GpdQ+/ YT-PTE is longer than for GpdQ+/ AYA-PTE.  In 
control experiments, the growth curves of E. coli BL21 cells in the presence of inorganic 
phosphate are the fastest and followed by E. coli BL21 cells in the presence of methyl 
phosphonate.    
            The growth curves of GpdQ+/PTE+ cells in the phosphate free MOPS minimal 
medium in the presence of the Sp-enantiomer of compound 5 are shown in Figure 4.5.   
                                                                                             
120
Time (hour)
0 20 40 60 80 100 120 140 160 180 200 220
O
D
60
0
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
 
 
 
Figure 4.5  Time courses for the growth of GpdQ+/wild-type PTE in the presence of Sp-
5 (△), GpdQ+/ GWT PTE  in the presence of Sp-5 (▓), GpdQ+/ mutant PTE GWT-d1 
(H254G/H257W/L303T/K185R/I274N) in the presence of Sp-5 (▽), GpdQ+/ GWT-f1 
PTE (H254G/H257W/L303T/K185R/I274N/ M317L) in the presence of Sp-5 (◆), 
GpdQ+/ GWT-f2 PTE (H254G/H257W/L303T/M317L) in the presence of Sp-5(◇), the 
control experiments are cells E. coli BL21 (DE3) in the presence of inorganic phosphate 
(○), methyl phosphonate(▼), and no phosphate source(●).  
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The cells of the GpdQ+/ PTE mutants (H254G/H257W/L303T (GWT), GWT-f1, GWT-
f2, and GWT-d1) growing on the Sp-enantiomer of compound 5 display similar lag 
phases of approximately 165 hours, but slightly different growth rates.  The GWT-f2 
mutant has the best growth rate compared to the other three PTE mutants.  The mutants 
that contain K185R/I274N were shown to have higher protein expression levels, so the 
intracellular concentration of PTE is higher and more substrate could be hydrolyzed to 
proceed the following phosphate assimilation catabolic pathway.  Therefore, to be able 
to enhance enzyme evolution, the GWT-f1 mutant was utilized as the template to create 
the PTE randomized library.  In vivo selection was performed to assess the next 
generation of beneficial mutants against the Sp- enantiomer of compound 5.  The results 
indicate that the growth rates are closely linked to the hydrolysis rate of PTE for 
organophosphonate diesters and GpdQ for methyl phosphonate monoesters, the 
expression levels of PTE is also a factor for the growth rates of the GpdQ+/PTE+ cells.  
           Discovery of the Active Variants towards the Sp- GF Analogue Using in vivo 
Selection. The GWT-f2 mutant (H254G/H257W/L303T/M317L) was found to be the 
best mutant for the hydrolysis of the Sp- GF analogue from the single substitution 
library.  The GWT-f1 mutant (H254G/H257W/L303T/M317L/K185R/I274N) with two 
additional K185R and I274N substitutions is higher in protein expression level.  
Therefore, the library with six randomized amino acid residues in the substrate binding 
pocket, Ile-106, Phe-132, Leu-271, Phe-306, Ser-308 and Tyr-309, was constructed 
using the gene of the GWT-f1 mutant as the template.  These six sites were randomized 
to different combinations of amino acid residues.  The Ile-106 residue was randomized 
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to 6 amino acids, the Phe-132 residue was randomized to 13 amino acids, the Leu-271 
residue was randomized to 5 amino acids, the Phe-306 residue was randomized to 4 
amino acids, the Ser-308 residue was randomized to 10 amino acids and the Tyr-309 
residue was randomized to 12 amino acids.  This library contains 1.87 X 105 variants.  
Eight colonies from this library were selected to verify that the targeted sites were 
randomized (Table 4.4).  The PTE library/GpdQ-pETDuet plasmid was transformed into 
E. coli BL21(DE3) cells and plated on LB agarose.  Approximately 5.8 X 105 cells were 
selected and grown on an agarose plate containing phosphate free MOPS minimal 
medium and 1 mM of the Sp- enantiomer of compound 5.  The colonies that contain 
beneficial mutations towards the hydrolysis of the Sp- enantiomer of compound 5 were 
identified as being larger in size than a background colony for the GWT-f1 mutant.  
Around 30 large-sized colonies were selected for growth on the 96-well blocks with the 
super broth culture and screened with the Sp- enantiomer of compound 5.  
            The screening of the multisite-randomized library with the Sp- enantiomer of 
compound 5 is shown in Figure 4.6 (A).  The first 9 samples include the following 
controls: BL21 (DE3) containing pETDuet (black), WT PTE (pink), the GWT-f1 mutant 
GWTRNL PTE (light green).  The GWT-f3 mutant 
(H254G/H257W/L303T/M317L/I106C/F132I/L271I/K185R/I274N) was found to have 
a 1.2-fold enhancement in the normalized rate against the Sp- enantiomer of compound 5 
compared to the GWT-f1 mutant.  Another mutant with twelve mutations, 
H254G/H257W/L303T/M317L/I106C/F132I/L271Y/F306L/S308C/Y309C/K185R/I274
N, was found to have positive result from the other screening, but the normalized rate is 
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Table 4.4  Sequence identifications of the PTE variants made from multisite randomized 
library using the gene for the GWT-f1 mutant as the template. 
 
 
 
 
 
 
 
 
 
 
No. Mutational sites from error-prone PCR 
1 I106V/F132I/L271Y/F306I/S308Q/Y309N 
2 I106V/F132I/L271Y/F306L/S308V/Y309S 
3 I106V/F132T/L271I/F306I/S308Q/Y309A 
4 I106C/F132F/L271L/F306F/S308Q/Y309V 
5 I106I/F132G/L271G/F306L/S308T/Y309S 
6 I106C/F132F/L271L/F306M/S308T/Y309G 
7 I106V/F132A/L271Y/F306I/S308E/Y309G 
8 I106M/F132I/L271L/F306M/S308L/Y309Y 
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Figure 4.6  (A) Screening of 6 site randomized library from in vivo selection. (B) 
Screening of error-prone PCR library from in vivo selection.  Both of them were the Sp- 
enantiomer of compound 5.   
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slower than the GWT-f1control.  The A80V mutation was added to the GWT-f3 mutant 
using QuikChange mutagenesis.  The purified GWT-f4 mutant 
(H254G/H257W/L303T/M317L/I106C/F132I/L271I/K185R/I274N/A80V) was shown 
to have a higher activity towards the Sp- enantiomer of compound 5 than the purified 
GWT-f3 mutant by 2 fold. 
           The GWT-f4 mutant served as the template for error-prone PCR (epPCR).  
Random mutagenesis of the GWT-f4 gene was conducted using Mutazyme II DNA 
polymerase®.  Ten colonies from this library were selected to verify the sequences, and 
they were shown to have ~1.5 mutations per 1000 kb gene on average.  The 
identification of these ten colonies is shown in Table 4.5. The epPCR PTE 
library/GpdQ-pETDuet plasmids were transformed into E. coli BL21(DE3) cells and  
grown on LB agarose plates.  Approximately 6 X 105 cells were selected and grown on 
the agarose plate containing the phosphate free MOPS minimal medium and 1 mM of 
the Sp- enantiomers of compound 5.  The colonies with a larger size than the background 
colony (the GWT-f4 mutant) were selected for growth in the super broth culture and 
screened with the Sp- enantiomer of compound 5.  The screening of the library created 
by error-prone PCR with the Sp- enantiomer of compound 5 is shown in Figure 4.6 (B). 
The first 20 samples comprise the following controls: BL21 (DE3) containing pETDuet 
(black), WT PTE (pink), the GWT-f3 mutant GWTRNLCIIV PTE (light green), 
GWTRNLCIIV-G129D PTE (cyan), GWTRNLCIIV-I288F PTE (dark blue), 
WTRNLCIIV-H254W PTE (dark yellow).  The GWT-f5 mutant 
(H254G/H257W/L303T/M317L/I106C/F132I/L271I/K185R/I274N/A80V/R67H) was 
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Table 4.5  Sequence identifications of the PTE variants made by error-prone PCR using 
the gene for the GWT-f4 mutant as the template.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No. Mutational sites from error-prone PCR 
1 L192R 
2 L130Q/N353S 
3 F51I/E159K  
4 I228F 
5 G129D 
6 3 silent mutations 
7 H254W 
8 V40I/L192M 
9 I288N/S308P 
10 Background – the GWT-f4 mutant 
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shown to have a 2-fold enhancement in the normalized rate against the Sp- enantiomer of 
compound 5 compared to the template, the GWT-f4 mutant.   Some positive results were 
found from other screening of the epPCR PTE library, however, 75% of them are the 
background or the GWT-f4 mutant with silent mutations.   
            Kinetic Properties of the PTE Mutants towards Organophosphonate Compounds.  
The kinetic parameters of the wild-type and mutants of PTE towards all of the 
organophosphonate compounds in Scheme 4.3 are presented in Tables 4.6 and 4.7.   The 
identification of the mutants in Tables 4.6 and 4.7 are shown in Table 4.8.  The RN 
mutant only contains mutations on the surface of PTE.  The protein expression level and 
solubility of the RN mutant are higher than the wild-type.  However, the catalytic 
efficiency is very similar to the wild-type.  The H254Q/H257F (QF) mutant was shown 
to have a small Km value towards the Sp-enantiomers of compounds 1, 2 and 3 in 
Chapter III, which suggests that the substrate binding affinity is better,  The QFRN 
mutant also has lower Km values against the Sp-enantiomers of compounds 1, 2 and 3 
(less than 10 μM).  In addition, the YTRN mutant also possesses similar kinetic 
properties with the H257Y/L303T (YT) mutant against all of the substrates.  The most 
different point is the catalytic activity against the Sp- enantiomer of compound 3, the kcat 
value of the YTRN mutant is 7.5-fold higher and the kcat/Km value is 5-fold higher than 
the H257Y/L303T (YT) mutant.    
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Table 4.6  kcat values (s-1) for the wild-type and mutants of PTE. 
 
a ND represents the enzymes were not saturated under 3mM of the substrates.  
 
 
 WT RN QFRN YTRN GWT GWT-d1 GWT-d2 GWT-d3 GWT-f1 GWT-f2 GWT-f3 GWT-f4 GWT-f5 
Rp/Sp-1 3.9e2 4.2e2 5.4e1 3.9e2 2.7e2 3.2e2 4.6e2 3.7e2 4.9e2 4.0e2 7.6e2 1.5e3 NDa 
Rp-1 1.5e2 9.0e1 2.0e2 1.2e1 1.4e1 1.4e1 1.3e1 9.6e0 1.3e1 2.2e2 7.9e1 ND ND 
Sp-1 6.7e2 8.2e2 4.5e1 1.0e3 1.9e2 2.9e2 5.3e2 4.0e2 3.6e2 4.4e2 6.6e2 1.1e3 7.2e2 
Rp/Sp-2 9.7e1 6.4e1 1.8e1 3.8e2 1.2e2 7.9e1 1.4e2 1.3e2 2.5e2 1.9e2 ND 9.7e2 8.1e2 
Rp-2 1.0e2 6.6e1 6.6e1 2.0e1 ND 2.1e1 2.2e1 5.9e1 9.8e0 3.3e1 ND ND ND 
Sp-2 4.0e1 2.0e1 1.1e1 7.0e2 9.2e1 8.6e1 1.3e2 2.0e2 3.0e2 2.3e2 6.2e2 1.1e3 5.9e2 
Rp/Sp-3 5.4e1 4.4e1 1.9e1 6.7e2 4.7e1 6.3e1 6.4e1 7.5e1 9.1e1 8.7e1 1.5e2 2.5e2 1.7e2 
Rp-3 9.3e1 4.8e1 1.3e2 4.3e1 2.0e1 8.0e0 1.3e1 2.2e1 2.9e1 3.4e1 1.3e1 1.5e1 ND 
Sp-3 2.2e1 1.6e1 1.3e1 7.7e2 5.0e1 5.5e1 5.8e1 6.0e1 8.0e1 8.8e1 1.4e2 2.5e2 1.8e2 
RpRc/RpSc 
/SpRc/SpSc-4 
2.1e0 3.2e0 1.6e0 4.1e0 1.8e1 1.6e1 3.0e1 2.2e1 2.6e1 2.2e1 ND ND ND 
RpRc/SpRc-4 2.5e0 3.3e0 1.4e0 6.6e0 1.1e1 1.8e1 2.7e1 2.6e1 4.4e1 3.8e1 ND ND ND 
RpSc/SpSc-4 6.1e-1 1.0e0 7.0e-1 1.9e0 4.6e0 6.4e0 2.0e1 1.3e1 5.9e0 1.0e1 ND 8.9e0 ND 
RpRc-4 3.4e0 4.5e0 1.1e0 5.8e-1 2.0e0 2.4e0 4.3e0 ND 4.0e0 ND ND ND 2.9e0 
RpSc-4 4.5e-1 4.2e-1 3.3e-1 1.9e0 2.1e-1 1.4e0 ND ND 8.9e-1 1.9e0 ND ND 1.9e0 
SpRc-4 7.7e-1 1.3e0 1.2e0 4.3e0 1.2e1 1.4e1 5.0e1 6.4e1 3.1e1 3.1e1 1.6e1 4.7e1 1.7e1 
SpSc-4 1.6e-2 ND 5.1e-1 3.2e0 2.9e0 6.5e0 1.2e1 2.4e1 5.7e1 8.1e0 4.2e0 5.6e0 6.1e0 
Rp/Sp-5 2.8e1 3.0e1 2.6e1 8.9e0 1.3e1 3.2e0 3.9e1 4.3e1 2.2e1 3.8e1 4.0e1 5.4e1 6.4e1 
Rp-5 ND 2.5e1 2.2e1 1.7e1 8.1e-1 ND 9.7e-1 ND ND ND 2.2e0 ND 3.3e0 
Sp-5 ND 1.3e-1 4.1e-1 7.2e0 1.9e1 3.1e0 4.7e1 4.4e1 2.6e1 3.1e1 4.4e1 1.2e2 1.2e2 
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Table 4.7  kcat/Km (M-1s-1) for the wild-type and mutants of PTE.  
 
 
 
 WT RN QFRN YTRN GWT GWT-d1 GWT-d2 GWT-d3 GWT-f1 GWT-f2 GWT-f3 GWT-f4 GWT-f5 
Rp/Sp-1 7.2e5 4.0e5 4.9e6 9.0e4 7.8e4 1.2e5 5.5e5 4.1e5 2.4e5 3.3e5 7.9e4 9.1e4 1.2e5 
Rp-1 4.9e5 1.7e5 3.0e6 4.3e3 1.5e3 2.5e3 6.1e3 9.1e3 1.0e5 5.2e4 6.1e3 7.2e3 8.5e3 
Sp-1 1.2e6 7.4e5 8.0e6 1.7e5 2.2e5 1.9e5 1.2e6 1.2e6 7.2e5 6.2e5 1.3e5 2.3e5 2.9e5 
Rp/Sp-2 2.4e5 1.6e5 1.4e6 7.0e4 4.0e4 4.4e4 2.0e5 2.8e5 7.7e4 1.1e5 4.5e4 1.3e5 1.6e5 
Rp-2 5.8e5 2.8e5 1.6e6 3.4e3 1.8e3 3.5e3 6.0e3 8.1e3 1.4e4 4.7e3 3.4e3 4.2e3 6.1e3 
Sp-2 2.7e4 2.6e4 1.6e6 1.4e5 5.9e4 8.6e4 4.6e5 4.3e5 1.4e5 1.9e5 1.2e5 2.4e5 4.2e5 
Rp/Sp-3 2.7e5 2.2e5 1.1e6 2.0e5 9.9e4 1.6e5 2.8e5 4.7e5 1.4e5 4.6e5 3.0e5 1.1e6 7.4e5 
Rp-3 8.5e5 4.0e5 1.3e6 1.3e4 1.5e3 3.0e3 5.4e3 7.6e3 3.3e3 3.8e3 8.2e2 2.6e3 2.2e3 
Sp-3 3.4e4 4.8e4 1.4e6 3.9e5 1.8e5 5.0e5 1.1e6 1.2e6 6.7e5 1.0e6 1.1e6 2.3e6 1.9e6 
RpRc/RpSc 
/SpRc/SpSc-4 
3.8e2 4.8e2 4.7e2 7.0e2 1.9e3 3.3e3 1.0e4 9.2e3 3.4e3 3.5e3 9.3e2 1.3e3 1.4e3 
RpRc/SpRc-4 5.4e2 1.2e3 9.9e2 1.2e3 3.3e3 6.4e3 1.8e4 1.7e4 4.9e3 5.3e3 1.5e3 2.3e3 2.1e3 
RpSc/SpSc-4 1.2e2 2.0e2 1.1e2 2.9e2 7.7e2 1.6e3 3.3e3 3.3e3 1.2e3 1.9e3 4.6e2 9.2e2 6.4e2 
RpRc-4 1.3e3 3.0e3 2.8e2 3.0e2 2.2e2 6.8e2 6.4e2 5.6e2 4.2e2 4.1e2 6.3e2 7.9e2 8.5e2 
RpSc-4 2.0e2 4.6e2 7.4e1 1.9e2 1.3e2 1.2e2 1.5e2 1.4e2 2.1e2 1.4 e2 1.4e2 2.0e2 1.8e2 
SpRc-4 1.1e2 2.3e2 1.8e3 1.2e3 8.1e3 2.3e4 6.0e4 8.7e4 1.3e4 1.4e4 3.2e3 5.0e3 3.8e3 
SpSc-4 3.2e0 1.5e1 9.6e1 4.8e2 1.7e3 4.2e3 8.1e3 1.1e4 2.6e3 2.5e3 1.5e3 1.5e3 1.2e3 
Rp/Sp-5 7.4e3 7.1e3 4.6e3 9.1e3 1.5e4 4.7e3 7.8e4 7.2e4 2.6e4 2.1e4 3.3e4 9.2e4 9.2e4 
Rp-5 1.6e4 1.7e4 9.0e3 3.5e3 2.5e2 3.0e2 5.4e2 5.5e2 6.0e2 8.6e2 4.5e2 5.1e2 7.7e2 
Sp-5 2.1e1 2.8e1 3.6e2 1.4e4 2.8e4 1.0e4 5.2e4 1.5e5 3.9e4 7.7e4 1.2e5 2.5e5 3.2e5 
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Table 4.8  Identification of active PTE mutants.  
 
 
 
 
 
 
 
 
 
Abbreviation 
of mutants Mutational sites of mutants 
RN K185R/I274N 
QFRN H254Q/H257F/K185R/I274N 
YTRN H257Y/L303T/K185R/I274N 
GWT-d1 H254G/H257W/L303T/K185R/I274N 
GWT-d2 H254G /H257W/L303T/K185R/I274N/A80V 
GWT-d3 H254G/H257W/L303T/K185R/I274N/A80V/S61T 
GWT-f1 H254G/H257W/L303T/M317L/K185R/I274N 
GWT-f2 H254G/H257W/L303T/M317L 
GWT-f3 H254G/H257W/L303T/M317L/I106C/F132I/L271I/K185R/I274N 
GWT-f4 H254G/H257W/L303T/M317L/I106C/F132I/L271I/K185R/I274N/A80V 
GWT-f5 H254G/H257W/L303T/M317L/I106C/F132I/L271I/K185R/I274N/A80V/R67H 
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           The GWT-d1, GWT-d2 and GWT-d3 mutants display an enhanced activity 
towards the two Sp- enantiomers of compound 4, the analogues of the more toxic 
enantiomers of soman, relative to the H254G/H257W/L303T (GWT) mutant. The 
beneficial mutations, A80V, K185R and I274N, which are located at the surface of the 
protein can help protein solubility and increase the catalytic activity towards the Sp- 
enantiomers of compound 4.  Using the GWT-d2 mutant as a template, the GWT-d3 
mutant was isolated by the screening methodology and shown to have the highest 
activity against the Sp- enantiomers of compound 4.  The kcat/Km values of  the GWT-d3 
mutant against SpRc- and SpSc- enantiomers of compound 4 are 8.7 x 104 and 1.1 x 104 
M-1s-1, respectively.   
           The GWT-f1, GWT-f2 and GWT-f3 mutants were shown to have enhanced 
activity towards the Sp- enantiomer of compound 5 compared to the 
H254G/H257W/L303T (GWT) mutant.  The M317L mutation of the GWT-f1 mutant 
was found by screening with the Sp- enantiomer of compound 5.  The GWT-f3 and 
GWT-f5 mutant were identified from the in vivo selection with PTE and GpdQ 
coexpressing E. coli cells on the phosphate free minimal medium agarose plate with the 
Sp-enantiomer of compound 5 as the sole phosphorus source.  Through this selection 
technique, the GWT-f5 mutant is the best mutant for the hydrolysis of the Sp-enantiomer 
of compound 5.  The kcat/Km value is 3.2 x 105 M-1s-1.   The procedure for the discovery 
of the PTE variants that have enhanced activity for the hydrolysis of the Sp-enantiomers 
of compound 4 and 5 by directed evolution is shown in Scheme 4.5.             
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Scheme 4.5  Schematic representation of the directed evolution of PTE variants that 
contains enhanced activity towards the Sp- enantiomers of compounds 4 and 5. 
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            Structural Analysis of the Beneficial Mutants.  The structures of the substrate 
binding pockets of the wild-type PTE (PDB: 1HZY) and mutants, H254Q/H257F (QF) 
(PDB: 2OQL), H254G/H257W/L303T (GWT) (PDB: 1P6B), QFRN, GWT-d3, GWT-f5 
are shown in Figure 4.7.  The metals in the wild-type, H254Q/H257F (QF) and 
H254G/H257W/L303T (GWT) structures are zinc, whereas the metals in the QFRN, 
GWT-d3 and GWT-f5 structures are cobalt.  The backbone conformation of the residues 
in the substrate binding pocket and the rest of the protein are close.  Superposition of 
QFRN, GWT-d3 and GWT-f5 mutants with the wild-type PTE (PDB: 1HZY) provides a 
Cα atom rmsd values of 0.37, 0.38 and 0.71 Å, respectively.  The phenyl ring in Phe-132 
of the H254Q/H257F (QF) mutant (Figure 4.7(B)) rotates to a different position.  The 
two positions of the phenyl ring of Phe-132 are observed in the H257Y/L303T structure 
(PDB: 2OB3) at high resolution (1.04 Å).  One of the most noticeable differences from a 
comparison of the structures of H254G/H257W/L303T (GWT), GWT-d3 and GWT-f5 
mutants is that the indole group of Trp-257 in the GWT-f5 mutant is closer to Leu-317 
by 2.2 Å.  This may be because the branched chain of the leucine residue in the GWT-f5 
mutant provides more space for the Trp-257 residue compared to the longer chain of 
methionine.  The I106C substitution of the GWT-f5 mutant has changed from a bulkier 
isoleucine group to a smaller thiol group.   
              The substitutions in the QFRN, GWT-d3 and GWT-f5 mutants are labeled in 
pink in Figure 4.8 (A), Figure 4.9(A) and Figure 4.10(A).  The K185R and I274N 
mutations are located on the surface of the protein, Arg-185 is located on the external 
surface of the fourth α-helix and Asn-274 is located in loop 7.  The side chain of
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Figure 4.7  The substrate binding pocket of the wild-type and mutants of PTE. (A) wild-
type (1HZY), (B) H254Q/H257F (2OQL), (C) H254G/H257W/L303T (1P6B) (D) 
QFRN, (E) GWT-d3 and (F) GWT-f5. 
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the Val-80 mutation is pointed outward at the first α-helix.  The R67H mutation in the 
GWT-f5 mutant is located at the dimer interface (Figure 4.10 (C)).  The two histidines 
at position 67 from two different subunits are stacked with an imidazole molecule, which 
was one of the components used for crystallization.   
           The K185R mutation in QFRN, GWT-d3 and GWT-f5 is shown to have hydrogen 
bond interactions with Ser-218 and Glu-219.  The Arg-185 residue of the QFRN and 
GWT-f5 mutants (Figure 4.8(B) and Figure 4.9(B)) are slightly closer to Ser-218 
compared to the GWT-d3 structure.  However, the GWT-d5 mutant has a 3.3 Å distance 
between N  of Arg-185 and the carbonyl oxygen of Glu-181 on another side, this allows 
a hydrogen bond interaction of N  of Arg-185 and the oxygen of the carbonyl group of 
Glu-181.  The distance between Nδ of Arg-185 and the oxygen of the carbonyl group of 
Glu-181 is 3.6 Å (Figure 4.9(B)).  This suggests the Arg-185 residues in QFRN, GWT-
d3 and GWT-f5 may be flexible on the surface of the protein to provide hydrogen 
bonding interaction between residues Glu-181, Ser-218 and Glu-219.  However, the Lys-
185 residue of the H254Q/H257F (QF) and H254G/H257W/L303T (GWT) mutants 
cannot form any hydrogen bonds with peripheral amino acid residues.   
           The I274N mutation is a change from a hydrophobic residue to a hydrophilic 
residue.  In the case of the GWT-d3 mutant, the nitrogen and the oxygen of the side 
chain of Asn-274 are within the hydrogen bonding distance with the main chain amino 
and carbonyl groups (3.1 and 3.2 Å) (Figure 4.9(C)).  However, the same circumstance 
is not shown in the QFRN mutant (Figure 4.8(C)).  This implies the mutation of IIe-274  
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Figure 4.8  (A) The substitutions in the QFRN mutant. (B)(C) Comparisons of the 
QFRN (blue) and the H254Q/H257F (QF) (orange) structures 
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Figure 4.9  (A) The substitutions in the GWT-d3 mutant. (B)(C) Comparisons of the 
GWT-d3 (cyan) and the H254G/H257W/L303T (GWT) (yellow) structures. 
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Figure 4.10  (A) The substitutions in the GWT-f5 mutant. (B) The K185R mutation of 
the GWT-f5. (C) Comparisons of His-67 and Arg-67 of the GWT-f5 (green) and the 
H254G/H257W/L303T(GWT) (yellow) structures.  
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to asparagine can provide more flexible movements for the residues on the surface of the 
protein. 
 
Discussion 
            Wild-type PTE has a significant hydrolytic activity towards paraoxon.  The kcat 
value is ~ 104 s-1 and kcat/Km ~ 108 M-1 s-1.  However, the catalytic efficiency of the wild-
type enzyme for the hydrolysis of organophosphorus nerve agents is significantly 
smaller, and for the hydrolysis of the more toxic Sp-enantiomers of organophosphorus 
nerve agents is even smaller.  In Chapter III, the wild-type enzyme was shown to have a 
larger discrimination between the Rp and Sp-enantiomers when the substituents of the 
organophosphonate compounds (Scheme 4.4) are larger in size.  The H254Q/H257F 
(QF) mutant was shown to have highest activity towards the more toxic Sp-enantiomers 
of VX, sarin and rVX analogues, compound 1, 2 and 3.  The H254G/H257W/L303T 
mutant possessed the highest hydrolytic activity towards the more toxic Sp-enantiomers 
of soman and cyclosarin analogues, compound 4 and 5.  These mutants were selected for 
further modification to increase the hydrolysis activity by saturation mutagenesis and 
directed evolution.  
            The addition of K185R and I274N mutations to the wild-type and mutants of 
PTE increases protein expression levels and solubility.  These two mutations could also 
enhance the hydrolytic activity for some of the compounds in Scheme 4.3.  The QFRN 
mutant has higher kcat and kcat/Km values towards most of the compounds compared to 
the H254Q/H257F (QF) mutant.  Thus, the QFRN mutant is shown to have the best 
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activity towards the more toxic Sp-enantiomers of VX and sarin analogues, compound 1 
and 2.  The enhancements are 7- and 60-fold higher than the wild-type, and the kcat/Km 
values are more than 106 M-1s-1 (Figure 4.11).             
             An in vitro screening technique was utilized to isolate the GWT-f1 mutant, 
which has a 3-fold higher activity than H254G/H257W/L303T (GWT) towards the Sp-
enantiomer of the cyclosarin analogue, compound 5.   It is 3720-fold more active than 
the wild-type enzyme.  The GWT-f1 and GWT-f2 mutants were coexpressed with GpdQ 
in E. coli cells.  The cells could grow in a phosphate free minimal medium with a 165-
hour lag phase using the Sp- enantiomer of compound 5 as the sole phosphorus source.  
Therefore, the in vivo selection technique is practical when using the Sp- enantiomer 
compound 5.  The GWT-f3 and GWT-f5 mutants were selected from the in vivo 
selection on the phosphate free MOPS minimal medium agarose plate.  The GWT-f5 
mutant was shown to have a 15,500-fold enhancement in kcat/Km for the hydrolysis of 
the more toxic Sp- enantiomer of compound 5 relative to the wild-type enzyme, and the 
kcat/Km value is more than 3 x 105 M-1s-1 (Figure 4.12).  Surprisingly, the GWT-f4 
mutant that was found to enhance the activity against the Sp- enantiomer of compound 5 
and it displays the best activity towards the of the Sp- enantiomer of compound 3.  The 
kcat/Km value of GWT-f4 towards the Sp- enantiomer of compound 3 is higher than 2 x 
106 M-1s-1 and 68 fold higher than the wild-type PTE (Figure 4.11).  The GWT-f4 and 
GWT-f5 mutants comprise three distal mutations, A80V, K185R and I274N. 
            In a previous study, the inability of GpdQ to hydrolyze the hydrolysis product of 
soman, pinacolyl methyl phosphonate was demonstrated.  Thus, the growth of GpdQ+  
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Figure 4.11  Bar graphs illustrating increased values of kcat/Km (M-1s-1)for the Sp-
enantiomers of compound 1, 2 and 3 catalyzed by the wild-type and mutants of PTE. 
The numbers represent the increase in activity for the mutants relative to the wild-type 
enzyme.  
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Figure 4.12  Bar graphs illustrating increased values of kcat/Km (M-1s-1) for the Sp-
enantiomers of compound 4 and 5 catalyzed by the wild-type and mutants of PTE. The 
numbers represent the increase in activity for the mutants relative to the wild-type 
enzyme.  
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cells in a phosphorus minimal medium could not be observed in the presence of 
pinacolyl methyl phosphonate (XY Eman).  This result shows the incapability of using 
in vivo selection for the discovery of the active mutants against the Sp- enantiomers of 
compound 4.  Nevertheless, the utilization of in vitro screening technique and the 
involvement of some sensitive distal mutations were able to isolate more active mutants 
that were based on the H254G/H257W/L303T (GWT) mutant as the template. The 
GWT-d3 mutant was discovered as the most active mutant to hydrolyze the more toxic 
Sp- enantiomers of the soman analogues, compound 4.  The kcat/Km values of the GWT-
d3 mutant towards the SpRc and the SpSc - enantiomers of soman analogues are 780-and 
3530-fold higher than the wild-type PTE.   
           The distal mutations, A80V, K185R and I274N, which are located at the surface 
of PTE can enhance protein expression. The R67H mutation is located at the dimer 
interface of PTE.  These mutations are more than 17 Å away from the active site, and the 
sensitivity for the catalytic efficiency is not as high as the amino acid residues that reside 
the substrate binding pocket.  However, these residues may be might be able to facilitate 
the entry of the substrate and increase the substrate binding affinity.  The I106C, F132I 
and L271I mutations and the changes beyond the active site of the GWT-f5 mutant may 
make the protein more flexible than the H254G/H257W/L303T mutant for the entry of 
the Sp- enantiomer of compound 5.  
          The X-ray crystal structures of the QFRN, the GWT-d3 and the GWT-f5 mutants 
show that the K185R and I274N mutations provide more hydrogen bonding interactions 
with the adjacent amino acid resides.  In a previous study, the RN mutant was shown to 
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have 13-fold higher activity for the hydrolysis of paraoxon compared to the wild-type 
PTE (28).  However, we have only observed a 2-fold enhancement (data not shown), and 
the other mutants with these two mutations could also increase the hydrolysis activity 
towards some of the organophosphonate compounds approximately 2-fold.  Molecular 
modeling of the RN mutant showed that Glu-219 and Glu-181 can form hydrogen bonds 
with Arg-185.  The Arg-185 residue could partition between these two glutamate 
residues.  In addition, Glu-263 could potentially form a hydrogen bond with the Asn-274 
residue (28).  The observation from the crystal structures of the QFRN, GWT-d3 and the 
GWT-f5 mutants, additional residue Ser-218 can also form hydrogen bond with Arg-
185.  It makes the side chain of Arg-185 be closer to the side that has Ser-218 and Glu-
219.  Furthermore, the measurements of the I274N mutation and Glu-263 demonstrate 
their distances are not allowed to form hydrogen bonds.  These three crystal structures 
indicate the K185R and I274N mutations provide more hydrogen bonding interactions 
with neighboring amino acid residues and water molecules which could facilitate the 
protein solubility and flexibility at the surface.  The A80V mutation has a change to a 
bulkier and nonpolar side chain.  It is also located at the protein surface, suggesting it 
may provide more efficient protein folding and contribute to protein stability.  Overall, 
three distal mutations, A80V, K185R and I274N, could enhance protein expression level 
and hydrolytic activity towards most of the substrates.  They might play an important 
role in improving the flexibility of the active site of PTE and assisting the entrance of 
organophosphonate compounds.   A comparison with Arg- 67 of the 
H254G/H257W/L303T (GWT) mutant and His-67 of the GWT-f5 mutant, the two 
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arginines from different subunits forms hydrogen bonds to each other and the mutation 
to histidine at position 67 could weaken the hydrogen bond interaction between two 
monomers of PTE.  The pi-pi stacking of two histidines with an imidazole molecule 
would not be present when there is no imidazole in the condition of measuring kinetic 
parameters.   Therefore, the R67H mutation might provide more protein flexibility for 
the hydrolysis of the Sp- enantiomer of compound 5. 
 
Conclusion 
            The combination of saturation mutagenesis and directed evolution of PTE was 
able to alter stereoselectivity and enhance the catalytic activity towards unfavorable 
substrates.  The wild-type PTE preferentially hydrolyze the Rp-enantiomers of 
organophosphate nerve agents and analogues relative to the Sp- enantiomers.   The 
H254G/H257W/L303T (GWT) mutant from the first generation was shown to have 
reversed stereoselectivity and enhanced the catalytic activity towards the more toxic Sp-
enantiomers of soman (GD) and cyclosarin (GF) analogues.   The structural modification 
of the GWT mutant on the substrate binding pocket, surface and dimmer interface might 
facilitate the binding and the entrance of the Sp-enantiomers of soman and cyclosarin 
analogues to the active site.  The second generation of mutants, the GWT-d3 and 
theGWT-f5, was discovered as the best mutants to catalyze hydrolysis of the Sp-
enantiomers of soman and cyclosarin analogues, respectively.  The kcat/Km values of the 
GWT-d3 mutant towards the SpRc and SpSc – enantiomers of soman analogue are 780- 
and 3530-fold higher than the wild-type enzyme.  The kcat/Km value of the GWT-f5 
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mutant towards the Sp-enantiomer of cyclosarin analogue is 15500-fold higher than the 
wild-type enzyme.
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CHAPTER V 
SUMMARY AND CONCLUSIONS 
 
            Phosphotriesterase (PTE) is an enzyme isolated from soil bacteria, Pseudomonas 
diminuta MG and Flavobcterrium sp. strains.  This enzyme is known for the ability to 
catalyze the detoxification of organophosphate pesticides and chemical warfare agents.  
The catalytic ability of PTE for the hydrolysis of paraoxon is close to the limit of 
diffusion of the reactant in solution. The kcat and kcat/Km values are ~10
4 s-1 and 108
 
M-1s-1 
respectively.  The substrate specificity of PTE is fairly broad.  It is capable of 
hydrolyzing organophosphorus nerve agents including tabun (GA), sarin (GB), soman 
(GD), cyclosarin (GF), rVX, and VX.  However, the catalytic activity of PTE for the 
organophosphate nerve agents is lower than paraoxon.  It was reported that the wild-type 
PTE is more efficient in catalyzing the hydrolysis of the less toxic Rp- enantiomers of 
organophosphate nerve agents and their analogues (GB and GD analogues) than the 
more toxic Sp- enantiomers (45).   The real nerve agents are not allowed to be handled in 
the regular laboratories, thus the GB, GD, GF, rVX and VX  analogues with para-acetyl 
phenol as the leaving group were utilized to study the kinetic properties of the wild-type 
and mutants of PTE.  
            The modification of the physical size and configuration of the binding pockets 
could alter the substrate stereoselectivity of PTE and increase the catalytic efficiency to 
hydrolyze the more toxic Sp- enantiomers of the nerve agents.  The H254Q/H257F (QF) 
mutant of PTE modifies the configuration of the large pocket.   The substrate binding 
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affinity of this mutant towards the Sp- enantiomers of VX, GB and rVX analogues are 
relatively high, with Km values that are lower than 10 μM.  The kcat/Km values for the Sp-
enantiomers of VX, GB and rVX analogues are more than 106 M-1s-1.  The 
H254G/H257W/L303T (GWT) mutant has an expanded small pocket and an enlarged 
large pocket in the substrate binding site.  It is shown to have a reversed stereoselectivity 
for the hydrolysis of the organophosphorous nerve agent analogues.  The more toxic Sp- 
enantiomers of organophosphonates are preferred to be hydrolyzed by this mutant.  The 
hydrolysis of the SpRc- and SpSc-enantiomers of the GD analogues by this mutant are 
enhanced by 73- and 543- fold, respectively, relative to the wild-type enzyme, with 
kcat/Km values of 103 M-1s-1.  The kcat/Km value of this mutant is around 104 M-1s-1 for the 
hydrolysis of the Sp-enantiomer of the GF analogues, which is 1340-fold higher than the 
wild-type enzyme.  Therefore, mutations in the active site using the 
H254G/H257W/L303T (GWT) mutant as the template allow further enhancement in 
activity for the hydrolysis of the nerve agents and their analogues. 
            The mutations at the surface of PTE were introduced to several beneficial 
mutants.  The A80V, K185R and I274N mutations were shown be important for the 
increase in protein expression levels, protein solubility and catalytic activity against 
some of the substrates.  The QFRN mutant has the additional K185R and I274N 
mutations compared to the H254Q/H257F (QF) mutant.  The kcat/Km values of the QFRN 
mutant towards the Rp- and Sp- enantiomers of VX and GB analogues are further 
enhanced.   The GWT-d2 mutant has the A80V, K185R and I274N mutations that have 
been added to the H254G/H257W/L303T (GWT) mutant.  The kcat/Km values of the 
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GWT-d2 mutant towards the SpRc- and the SpSc - enantiomers of the GD analogues have 
been further enhanced by 540- and 2570-fold relative to the wild-type enzyme, 
respectively. 
           The single and double substitution libraries of PTE, M317X and C59X/S61X, 
were created using QuikChange site-directed mutagenesis. The primers of QuikChange 
mutagenesis contain the degenerate codon, NNS, at the target positions, which was used 
to eliminate two stop codons, TGA and TAA (N = A, T, G, C; S= C, G).  The 
QuikChange  PCR products were transformed into E. coli BL-21 competent cells and 
inoculated into 96 deep-well culture blocks.  The in vitro screening technique was 
conducted to make all possible PTE variants in the culture blocks.  These variants were 
then screened for activity with paraoxon, and the Sp-enantiomers of the GD and GF 
analogues.  The libraries were constructed using the sequences of the GWT-d1 and the 
GWT-d2 mutants as templates, which have been shown to have higher protein 
expression levels than the H254G/H257W/L303T (GWT) mutant.  The PTE mutants that 
show promising activities were selected to identify their sequences.  The GWT-f2 
mutant was identified and isolated.  The kcat/Km value of this mutant towards the 
hydrolysis of the Sp-enantiomer of the GF analogues is 3720-fold higher than the wild-
type enzyme.   In addition, the GWT-d3 mutant was identified as the best mutant 
towards the hydrolysis of the Sp-enantiomers of the GD analogues.   The kcat/Km values 
for the GWT-d3 mutant with the SpRc- and SpSc-enantiomers of the GD analogues were 
780- and 3530-fold higher than the wild-type enzyme, respectively.  
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           The randomization of multiple amino acid residues in the substrate binding 
pockets of PTE or the incorporation of random mutations to the gene of PTE by error-
prone PCR can create much larger libraries.  The in vivo selection methodology was 
utilized to isolate active mutants for the library size larger than 103 variants, which 
helped to reduce time and substrate consumption.  The modified PTE gene that encodes 
the enzyme with improved activity against the Sp-enantiomer of the GF analogue and the 
gene of glycerophosphodiester phosphodiesterase (GpdQ) were ligated into pET-Duet 
plasmid and transformed into E. coli (BL21) cells.  The cells were grown on phosphate 
free minimal media plates containing the Sp-enantiomer of the GF analogues as the sole 
phosphorus source and the growth rates of the cells were observed.  By in vivo selection, 
the GWT-f3 mutant was isolated and shown to have 5580-fold higher in activity towards 
the Sp-enantiomer of the GF analogues than the wild-type enzyme.  The GWT-f4 mutant 
contains an additional A80V mutation compared to the GWT-f3 enzyme.  The kcat/Km 
value towards the hydrolysis of the Sp-enantiomer of the GF analogue for this mutant 
was increased to 1.2 X 10
4
-fold higher than the wild-type enzyme.  Interestingly, the 
GWT-f4 mutant was determined as the most active enzyme towards the Sp-enantiomer 
of the rVX analogues.  The random mutagenesis library was subjected to the second 
round of in vivo selection, and the GWT-f5 mutant was discovered.  The kcat/Km value of 
the GWT-f5 towards the Sp-enantiomer of the GF analogues is 1.55 X 10
4
-fold higher 
than the wild-type enzyme.   
           The X-ray crystal structures of the wild-type PTE and the G60A mutant were 
determined in the presence of the hydrolysis product diethyl phosphate and a product 
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analogue cacodylate, respectively.  In the structure of the wild-type PTE-diethyl 
phosphate complex, the diethyl phosphate is symmetrically bridging between the two 
divalent metal cations.  Cacodylate is bound between two divalent metals in the G60A 
mutant structure.   The distance of the two metal ions in the liganded structures is 
approximately 4 Å compared with 3.4 Å in the unliganded complex.  This result 
supports the reaction mechanism proposed by Aubert et. al that the organophosphate 
substrate binds to the binuclear active site and displace a water molecule that is 
coordinating to the β-metal ion.  The interaction of the substrate with the β- metal ion 
weakens the coordination of the bridging hydroxide ion to the β- metal.  This activates 
the hydroxide ion to attack the phosphorus center of the substrate.  The collapse of the 
intermediate and the breakage of the P-O bond result in diethyl phosphate being bridged 
between the two divalent cations within the active site.  The binuclear metal center and 
the active site hydroxide are regenerated after the diethyl phosphate disassociated from 
the active site.    
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